Can’t we be friends?

Article Type
Changed
Thu, 03/28/2019 - 15:09
Display Headline
Can’t we be friends?

Can’t we just be friends? This is the disquieting question we ask someone when we want to set boundaries. It is meant to define expectation, level of trust and intimacy in a relationship.

We are capable of forming an astonishing variety of relationships with others. We form deep emotional connections with romantic partners, close family, and dear friends. We create more superficial ties with colleagues, distant family, and professionals. Understanding the nature of our relationships is important. There are reasons why professors should not engage in romantic relationships with their students: mixing relationships can lead to confusion and destroy trust. The risk for misunderstanding and harm to one or both parties increases as the intensity of the relationship increases. Can a professor who has a personal relationship with a student be objective? Does the student really want to be kissed or is she feigning interest for a better grade?

The stakes are even higher for us physicians. Forming inappropriate relationships with patients can result in the loss of your medical license. This seems obvious to most of us, but when we examine the appropriateness of other nonprofessional connections, it becomes less clear.

What if you have an intimate but nonsexual relationship with a patient? What about having a family member or close friend as a patient? Most medical ethicists say that any relationship other than the straightforward, professional doctor/patient one is improper. This strict definition exists primarily to protect our patients but also to help us. The highest levels of quality and service can only come from the sterile yet compassionate trust that occurs only in doctor/patient connections.

As a male dermatologist, something as seemingly innocuous as my following a female patient on Instagram puts our professional relationship at risk. If a patient views you as a friend as well as a doctor, would he hesitate to divulge things that are important to his health but inappropriate for a friend to know? Moreover, if I have such knowledge, won’t that impair the trust we share as friends? Such conundrums might hinder your ability to care for your patients and limit the quality of service they receive.

Social media have added many more levels to the already complex ways we can relate to our patients. There are Facebook friends, Snapchat buddies, and Twitter followers. Most of these are diminishingly shallow in terms of the depth and seriousness of the relationship, but they can be misconstrued. In most instances, keep it simple: I’m your doctor. You’re my patient.

When patients ask me to friend them, as they sometime do, I remind them: I’m not your brother or your son. I am not your friend. You pay me to provide a service, yet what I give cannot be bought. I work for you when I’m home. I worry about you when I drive to the office. Someday, I may save your life.

I’m your doctor. No, we cannot be Facebook friends.

Dr. Benabio is a partner physician in the department of dermatology of the Southern California Permanente Group in San Diego, and a volunteer clinical assistant professor at the University of California, San Diego. He is @dermdoc on Twitter.

References

Author and Disclosure Information

Publications
Topics
Legacy Keywords
Facebook, doctor-patient, relationship, twitter, snapchat, instagram
Sections
Author and Disclosure Information

Author and Disclosure Information

Can’t we just be friends? This is the disquieting question we ask someone when we want to set boundaries. It is meant to define expectation, level of trust and intimacy in a relationship.

We are capable of forming an astonishing variety of relationships with others. We form deep emotional connections with romantic partners, close family, and dear friends. We create more superficial ties with colleagues, distant family, and professionals. Understanding the nature of our relationships is important. There are reasons why professors should not engage in romantic relationships with their students: mixing relationships can lead to confusion and destroy trust. The risk for misunderstanding and harm to one or both parties increases as the intensity of the relationship increases. Can a professor who has a personal relationship with a student be objective? Does the student really want to be kissed or is she feigning interest for a better grade?

The stakes are even higher for us physicians. Forming inappropriate relationships with patients can result in the loss of your medical license. This seems obvious to most of us, but when we examine the appropriateness of other nonprofessional connections, it becomes less clear.

What if you have an intimate but nonsexual relationship with a patient? What about having a family member or close friend as a patient? Most medical ethicists say that any relationship other than the straightforward, professional doctor/patient one is improper. This strict definition exists primarily to protect our patients but also to help us. The highest levels of quality and service can only come from the sterile yet compassionate trust that occurs only in doctor/patient connections.

As a male dermatologist, something as seemingly innocuous as my following a female patient on Instagram puts our professional relationship at risk. If a patient views you as a friend as well as a doctor, would he hesitate to divulge things that are important to his health but inappropriate for a friend to know? Moreover, if I have such knowledge, won’t that impair the trust we share as friends? Such conundrums might hinder your ability to care for your patients and limit the quality of service they receive.

Social media have added many more levels to the already complex ways we can relate to our patients. There are Facebook friends, Snapchat buddies, and Twitter followers. Most of these are diminishingly shallow in terms of the depth and seriousness of the relationship, but they can be misconstrued. In most instances, keep it simple: I’m your doctor. You’re my patient.

When patients ask me to friend them, as they sometime do, I remind them: I’m not your brother or your son. I am not your friend. You pay me to provide a service, yet what I give cannot be bought. I work for you when I’m home. I worry about you when I drive to the office. Someday, I may save your life.

I’m your doctor. No, we cannot be Facebook friends.

Dr. Benabio is a partner physician in the department of dermatology of the Southern California Permanente Group in San Diego, and a volunteer clinical assistant professor at the University of California, San Diego. He is @dermdoc on Twitter.

Can’t we just be friends? This is the disquieting question we ask someone when we want to set boundaries. It is meant to define expectation, level of trust and intimacy in a relationship.

We are capable of forming an astonishing variety of relationships with others. We form deep emotional connections with romantic partners, close family, and dear friends. We create more superficial ties with colleagues, distant family, and professionals. Understanding the nature of our relationships is important. There are reasons why professors should not engage in romantic relationships with their students: mixing relationships can lead to confusion and destroy trust. The risk for misunderstanding and harm to one or both parties increases as the intensity of the relationship increases. Can a professor who has a personal relationship with a student be objective? Does the student really want to be kissed or is she feigning interest for a better grade?

The stakes are even higher for us physicians. Forming inappropriate relationships with patients can result in the loss of your medical license. This seems obvious to most of us, but when we examine the appropriateness of other nonprofessional connections, it becomes less clear.

What if you have an intimate but nonsexual relationship with a patient? What about having a family member or close friend as a patient? Most medical ethicists say that any relationship other than the straightforward, professional doctor/patient one is improper. This strict definition exists primarily to protect our patients but also to help us. The highest levels of quality and service can only come from the sterile yet compassionate trust that occurs only in doctor/patient connections.

As a male dermatologist, something as seemingly innocuous as my following a female patient on Instagram puts our professional relationship at risk. If a patient views you as a friend as well as a doctor, would he hesitate to divulge things that are important to his health but inappropriate for a friend to know? Moreover, if I have such knowledge, won’t that impair the trust we share as friends? Such conundrums might hinder your ability to care for your patients and limit the quality of service they receive.

Social media have added many more levels to the already complex ways we can relate to our patients. There are Facebook friends, Snapchat buddies, and Twitter followers. Most of these are diminishingly shallow in terms of the depth and seriousness of the relationship, but they can be misconstrued. In most instances, keep it simple: I’m your doctor. You’re my patient.

When patients ask me to friend them, as they sometime do, I remind them: I’m not your brother or your son. I am not your friend. You pay me to provide a service, yet what I give cannot be bought. I work for you when I’m home. I worry about you when I drive to the office. Someday, I may save your life.

I’m your doctor. No, we cannot be Facebook friends.

Dr. Benabio is a partner physician in the department of dermatology of the Southern California Permanente Group in San Diego, and a volunteer clinical assistant professor at the University of California, San Diego. He is @dermdoc on Twitter.

References

References

Publications
Publications
Topics
Article Type
Display Headline
Can’t we be friends?
Display Headline
Can’t we be friends?
Legacy Keywords
Facebook, doctor-patient, relationship, twitter, snapchat, instagram
Legacy Keywords
Facebook, doctor-patient, relationship, twitter, snapchat, instagram
Sections
Article Source

PURLs Copyright

Inside the Article

Dispensing with expert testimony

Article Type
Changed
Thu, 03/28/2019 - 15:09
Display Headline
Dispensing with expert testimony

Question: When a doctor could not find a dislodged biopsy guide wire, he abandoned his search after informing the patient of his intention to retrieve it at a later date. Two months later, he was successful in locating and removing the foreign body, but the patient alleged she suffered pain and anxiety in the interim. She filed a negligence lawsuit and, based on the “obvious” nature of her injuries, called no expert witness to testify on her behalf.

Dr. S.Y. Tan

Which of the following choices is best?

A. Expert testimony is always needed to establish the applicable standard of care in medical negligence lawsuits.

B. Although a plaintiff is not qualified to expound on medical matters, he/she can offer evidence from learned treatises and medical texts.

C. The jury is the one who determines whether a plaintiff can invoke either the res ipsa loquitur doctrine or the “common knowledge” rule to obviate the need for an expert witness.

D. This patient will likely win her case.

E. All are incorrect.

Answer: E. It is well-established law that the question of negligence must be decided by reference to relevant medical standards of care for which the plaintiff carries the burden of proving through expert medical testimony. Only a professional, duly qualified by the court as an expert witness, is allowed to offer medical testimony – whereas the plaintiff typically will be disqualified from playing this role because of the complexity of issues involved.

However, under either the doctrine of res ipsa loquitur (“the thing speaks for itself”) or the “common knowledge” rule, a court (i.e., the judge) may allow the jury to infer negligence in the absence of expert testimony.

The res doctrine is invoked where there is only circumstantial but no direct evidence, and three conditions are met: 1) The injury would not have occurred in the absence of someone’s negligence; 2) the plaintiff was not at fault; and 3) the defendant had total control of the instrumentality that led to the injury.

The closely related “common knowledge” rule relies on the everyday knowledge and experience of the layperson to identify plain and obvious negligent conduct, which then allows the judge to waive the expert requirement.

The two principles are frequently used interchangeably, ultimately favoring the plaintiff by dispensing with the difficult and expensive task of securing a qualified expert willing to testify against a doctor defendant.

The best example of res in action is the surgeon who inadvertently leaves behind a sponge or instrument inside a body cavity. Other successfully litigated examples include a cardiac arrest in the operating room, hypoxia in the recovery room, burns to the buttock, gangrene after the accidental injection of penicillin into an artery, air trapped subcutaneously from a displaced needle, and a pierced eyeball during a procedure.

A particularly well-known example is Ybarra v. Spangard, in which the patient developed shoulder injuries during an appendectomy.1 The Supreme Court of California felt it was appropriate to place the burden on the operating room defendants to explain how the patient, unconscious under general anesthesia throughout the procedure, sustained the shoulder injury.

The scenario provided in the opening question is taken from a 2013 New York case, James v. Wormuth, in which the plaintiff relied on the res doctrine.2 The defendant doctor had left a guide wire in the plaintiff’s chest following a biopsy and was unable to locate it after a 20-minute search. However, he was able to retrieve the wire 2 months later under C-arm imaging.

The plaintiff sued the doctor for pain and anxiety, but did not call any expert witness, relying instead on the “foreign object” basis for invoking the res doctrine. The lower court ruled for the doctor, and the court of appeals affirmed.

It reasoned that the object was left behind deliberately, not unintentionally, and that under the circumstances of the case, an expert witness was needed to set out the applicable standard of care, without which a jury could not determine whether the doctor’s professional judgment breached the requisite standard. The court also ruled that the plaintiff failed to satisfy the “exclusive control” requirement of the res doctrine, because several other individuals participated to an extent in the medical procedure.

Hawaii’s case of Barbee v. Queen’s Medical Center is illustrative of the “common knowledge” rule.3 Mr. Barbee, age 75 years, underwent laparoscopic nephrectomy for a malignancy. Massive bleeding complicated his postoperative course, the hemoglobin falling into the 3 range, and he required emergent reoperation. Over the next 18 months, the patient progressively deteriorated, eventually requiring dialysis and dying from a stroke and intestinal volvulus.

 

 

Notwithstanding an initial jury verdict in favor of the plaintiff’s children, awarding each of the three children $365,000, the defendants filed a so-called JNOV motion (current term is “judgment as a matter of law”) to negate the jury verdict, on the basis that the plaintiffs failed to present competent expert testimony at trial to prove causation.

The plaintiffs countered that the cause of death was within the realm of common knowledge, thus no expert was necessary. They asserted that “any lay person can easily grasp the concept that a person dies from losing so much blood that multiple organs fail to perform their functions.” Mr. Barbee’s death thus was not “of such a technical nature that lay persons are incompetent to draw their own conclusions from facts presented without aid.”

Hawaii’s Intermediate Court of Appeals disagreed with the plaintiffs, holding that although “Hawaii does recognize a ‘common knowledge’ exception to the requirement that a plaintiff must introduce expert medical testimony on causation … this exception is rare in application.” The court asserted that the causal link between any alleged negligence and Mr. Barbee’s death 17 months later is not within the realm of common knowledge.

It reasoned that the long-term effects of internal bleeding are not so widely known as to be analogous to leaving a sponge within a patient or removing the wrong limb during an amputation. Moreover, Mr. Barbee had a long history of preexisting conditions, including hypertension, diabetes, and cancer. He also suffered numerous and serious postoperative medical conditions, including a stroke and surgery to remove part of his intestine, which had become gangrenous.

Thus, the role that preexisting conditions and/or the subsequent complications of this type played in Mr. Barbee’s death was not within the knowledge of the average layperson.

The “common knowledge” rule is aligned with, though not identical to, the res doctrine, but courts are known to conflate the two legal principles, often using them interchangeably.4

Strictly speaking, the “common knowledge” waiver comes into play where direct evidence of negligent conduct lies within the realm of everyday lay knowledge that the physician had deviated from common practice. It may or may not address the causation issue.

On the other hand, res is successfully invoked when, despite no direct evidence of negligence and causation, the circumstances surrounding the injury are such that the plaintiff’s case can go to the jury without expert testimony.

References

1. Ybarra v. Spangard, 154 P.2d 687 (Cal. 1944).

2. James v. Wormuth, 997 N.E.2d 133 (N.Y. 2013).

3. Barbee v. Queen’s Medical Center, 119 Haw 136 (2008).

4. Spinner, Amanda E. Common Ignorance: Medical Malpractice Law and the Misconceived Application of the “Common Knowledge” and “Res Ipsa Loquitur” Doctrines.” Touro Law Review: Vol. 31: No. 3, Article 15. Available at http://digitalcommons.tourolaw.edu/lawreview/vol31/iss3/15.

Dr. Tan is professor emeritus of medicine and former adjunct professor of law at the University of Hawaii, and currently directs the St. Francis International Center for Healthcare Ethics in Honolulu. This article is meant to be educational and does not constitute medical, ethical, or legal advice. Some of the articles in this series are adapted from the author’s 2006 book, “Medical Malpractice: Understanding the Law, Managing the Risk,” and his 2012 Halsbury treatise, “Medical Negligence and Professional Misconduct.” For additional information, readers may contact the author at [email protected].

References

Author and Disclosure Information

Publications
Topics
Legacy Keywords
malpractice, expert witness, expert testimony, medical negligence
Sections
Author and Disclosure Information

Author and Disclosure Information

Question: When a doctor could not find a dislodged biopsy guide wire, he abandoned his search after informing the patient of his intention to retrieve it at a later date. Two months later, he was successful in locating and removing the foreign body, but the patient alleged she suffered pain and anxiety in the interim. She filed a negligence lawsuit and, based on the “obvious” nature of her injuries, called no expert witness to testify on her behalf.

Dr. S.Y. Tan

Which of the following choices is best?

A. Expert testimony is always needed to establish the applicable standard of care in medical negligence lawsuits.

B. Although a plaintiff is not qualified to expound on medical matters, he/she can offer evidence from learned treatises and medical texts.

C. The jury is the one who determines whether a plaintiff can invoke either the res ipsa loquitur doctrine or the “common knowledge” rule to obviate the need for an expert witness.

D. This patient will likely win her case.

E. All are incorrect.

Answer: E. It is well-established law that the question of negligence must be decided by reference to relevant medical standards of care for which the plaintiff carries the burden of proving through expert medical testimony. Only a professional, duly qualified by the court as an expert witness, is allowed to offer medical testimony – whereas the plaintiff typically will be disqualified from playing this role because of the complexity of issues involved.

However, under either the doctrine of res ipsa loquitur (“the thing speaks for itself”) or the “common knowledge” rule, a court (i.e., the judge) may allow the jury to infer negligence in the absence of expert testimony.

The res doctrine is invoked where there is only circumstantial but no direct evidence, and three conditions are met: 1) The injury would not have occurred in the absence of someone’s negligence; 2) the plaintiff was not at fault; and 3) the defendant had total control of the instrumentality that led to the injury.

The closely related “common knowledge” rule relies on the everyday knowledge and experience of the layperson to identify plain and obvious negligent conduct, which then allows the judge to waive the expert requirement.

The two principles are frequently used interchangeably, ultimately favoring the plaintiff by dispensing with the difficult and expensive task of securing a qualified expert willing to testify against a doctor defendant.

The best example of res in action is the surgeon who inadvertently leaves behind a sponge or instrument inside a body cavity. Other successfully litigated examples include a cardiac arrest in the operating room, hypoxia in the recovery room, burns to the buttock, gangrene after the accidental injection of penicillin into an artery, air trapped subcutaneously from a displaced needle, and a pierced eyeball during a procedure.

A particularly well-known example is Ybarra v. Spangard, in which the patient developed shoulder injuries during an appendectomy.1 The Supreme Court of California felt it was appropriate to place the burden on the operating room defendants to explain how the patient, unconscious under general anesthesia throughout the procedure, sustained the shoulder injury.

The scenario provided in the opening question is taken from a 2013 New York case, James v. Wormuth, in which the plaintiff relied on the res doctrine.2 The defendant doctor had left a guide wire in the plaintiff’s chest following a biopsy and was unable to locate it after a 20-minute search. However, he was able to retrieve the wire 2 months later under C-arm imaging.

The plaintiff sued the doctor for pain and anxiety, but did not call any expert witness, relying instead on the “foreign object” basis for invoking the res doctrine. The lower court ruled for the doctor, and the court of appeals affirmed.

It reasoned that the object was left behind deliberately, not unintentionally, and that under the circumstances of the case, an expert witness was needed to set out the applicable standard of care, without which a jury could not determine whether the doctor’s professional judgment breached the requisite standard. The court also ruled that the plaintiff failed to satisfy the “exclusive control” requirement of the res doctrine, because several other individuals participated to an extent in the medical procedure.

Hawaii’s case of Barbee v. Queen’s Medical Center is illustrative of the “common knowledge” rule.3 Mr. Barbee, age 75 years, underwent laparoscopic nephrectomy for a malignancy. Massive bleeding complicated his postoperative course, the hemoglobin falling into the 3 range, and he required emergent reoperation. Over the next 18 months, the patient progressively deteriorated, eventually requiring dialysis and dying from a stroke and intestinal volvulus.

 

 

Notwithstanding an initial jury verdict in favor of the plaintiff’s children, awarding each of the three children $365,000, the defendants filed a so-called JNOV motion (current term is “judgment as a matter of law”) to negate the jury verdict, on the basis that the plaintiffs failed to present competent expert testimony at trial to prove causation.

The plaintiffs countered that the cause of death was within the realm of common knowledge, thus no expert was necessary. They asserted that “any lay person can easily grasp the concept that a person dies from losing so much blood that multiple organs fail to perform their functions.” Mr. Barbee’s death thus was not “of such a technical nature that lay persons are incompetent to draw their own conclusions from facts presented without aid.”

Hawaii’s Intermediate Court of Appeals disagreed with the plaintiffs, holding that although “Hawaii does recognize a ‘common knowledge’ exception to the requirement that a plaintiff must introduce expert medical testimony on causation … this exception is rare in application.” The court asserted that the causal link between any alleged negligence and Mr. Barbee’s death 17 months later is not within the realm of common knowledge.

It reasoned that the long-term effects of internal bleeding are not so widely known as to be analogous to leaving a sponge within a patient or removing the wrong limb during an amputation. Moreover, Mr. Barbee had a long history of preexisting conditions, including hypertension, diabetes, and cancer. He also suffered numerous and serious postoperative medical conditions, including a stroke and surgery to remove part of his intestine, which had become gangrenous.

Thus, the role that preexisting conditions and/or the subsequent complications of this type played in Mr. Barbee’s death was not within the knowledge of the average layperson.

The “common knowledge” rule is aligned with, though not identical to, the res doctrine, but courts are known to conflate the two legal principles, often using them interchangeably.4

Strictly speaking, the “common knowledge” waiver comes into play where direct evidence of negligent conduct lies within the realm of everyday lay knowledge that the physician had deviated from common practice. It may or may not address the causation issue.

On the other hand, res is successfully invoked when, despite no direct evidence of negligence and causation, the circumstances surrounding the injury are such that the plaintiff’s case can go to the jury without expert testimony.

References

1. Ybarra v. Spangard, 154 P.2d 687 (Cal. 1944).

2. James v. Wormuth, 997 N.E.2d 133 (N.Y. 2013).

3. Barbee v. Queen’s Medical Center, 119 Haw 136 (2008).

4. Spinner, Amanda E. Common Ignorance: Medical Malpractice Law and the Misconceived Application of the “Common Knowledge” and “Res Ipsa Loquitur” Doctrines.” Touro Law Review: Vol. 31: No. 3, Article 15. Available at http://digitalcommons.tourolaw.edu/lawreview/vol31/iss3/15.

Dr. Tan is professor emeritus of medicine and former adjunct professor of law at the University of Hawaii, and currently directs the St. Francis International Center for Healthcare Ethics in Honolulu. This article is meant to be educational and does not constitute medical, ethical, or legal advice. Some of the articles in this series are adapted from the author’s 2006 book, “Medical Malpractice: Understanding the Law, Managing the Risk,” and his 2012 Halsbury treatise, “Medical Negligence and Professional Misconduct.” For additional information, readers may contact the author at [email protected].

Question: When a doctor could not find a dislodged biopsy guide wire, he abandoned his search after informing the patient of his intention to retrieve it at a later date. Two months later, he was successful in locating and removing the foreign body, but the patient alleged she suffered pain and anxiety in the interim. She filed a negligence lawsuit and, based on the “obvious” nature of her injuries, called no expert witness to testify on her behalf.

Dr. S.Y. Tan

Which of the following choices is best?

A. Expert testimony is always needed to establish the applicable standard of care in medical negligence lawsuits.

B. Although a plaintiff is not qualified to expound on medical matters, he/she can offer evidence from learned treatises and medical texts.

C. The jury is the one who determines whether a plaintiff can invoke either the res ipsa loquitur doctrine or the “common knowledge” rule to obviate the need for an expert witness.

D. This patient will likely win her case.

E. All are incorrect.

Answer: E. It is well-established law that the question of negligence must be decided by reference to relevant medical standards of care for which the plaintiff carries the burden of proving through expert medical testimony. Only a professional, duly qualified by the court as an expert witness, is allowed to offer medical testimony – whereas the plaintiff typically will be disqualified from playing this role because of the complexity of issues involved.

However, under either the doctrine of res ipsa loquitur (“the thing speaks for itself”) or the “common knowledge” rule, a court (i.e., the judge) may allow the jury to infer negligence in the absence of expert testimony.

The res doctrine is invoked where there is only circumstantial but no direct evidence, and three conditions are met: 1) The injury would not have occurred in the absence of someone’s negligence; 2) the plaintiff was not at fault; and 3) the defendant had total control of the instrumentality that led to the injury.

The closely related “common knowledge” rule relies on the everyday knowledge and experience of the layperson to identify plain and obvious negligent conduct, which then allows the judge to waive the expert requirement.

The two principles are frequently used interchangeably, ultimately favoring the plaintiff by dispensing with the difficult and expensive task of securing a qualified expert willing to testify against a doctor defendant.

The best example of res in action is the surgeon who inadvertently leaves behind a sponge or instrument inside a body cavity. Other successfully litigated examples include a cardiac arrest in the operating room, hypoxia in the recovery room, burns to the buttock, gangrene after the accidental injection of penicillin into an artery, air trapped subcutaneously from a displaced needle, and a pierced eyeball during a procedure.

A particularly well-known example is Ybarra v. Spangard, in which the patient developed shoulder injuries during an appendectomy.1 The Supreme Court of California felt it was appropriate to place the burden on the operating room defendants to explain how the patient, unconscious under general anesthesia throughout the procedure, sustained the shoulder injury.

The scenario provided in the opening question is taken from a 2013 New York case, James v. Wormuth, in which the plaintiff relied on the res doctrine.2 The defendant doctor had left a guide wire in the plaintiff’s chest following a biopsy and was unable to locate it after a 20-minute search. However, he was able to retrieve the wire 2 months later under C-arm imaging.

The plaintiff sued the doctor for pain and anxiety, but did not call any expert witness, relying instead on the “foreign object” basis for invoking the res doctrine. The lower court ruled for the doctor, and the court of appeals affirmed.

It reasoned that the object was left behind deliberately, not unintentionally, and that under the circumstances of the case, an expert witness was needed to set out the applicable standard of care, without which a jury could not determine whether the doctor’s professional judgment breached the requisite standard. The court also ruled that the plaintiff failed to satisfy the “exclusive control” requirement of the res doctrine, because several other individuals participated to an extent in the medical procedure.

Hawaii’s case of Barbee v. Queen’s Medical Center is illustrative of the “common knowledge” rule.3 Mr. Barbee, age 75 years, underwent laparoscopic nephrectomy for a malignancy. Massive bleeding complicated his postoperative course, the hemoglobin falling into the 3 range, and he required emergent reoperation. Over the next 18 months, the patient progressively deteriorated, eventually requiring dialysis and dying from a stroke and intestinal volvulus.

 

 

Notwithstanding an initial jury verdict in favor of the plaintiff’s children, awarding each of the three children $365,000, the defendants filed a so-called JNOV motion (current term is “judgment as a matter of law”) to negate the jury verdict, on the basis that the plaintiffs failed to present competent expert testimony at trial to prove causation.

The plaintiffs countered that the cause of death was within the realm of common knowledge, thus no expert was necessary. They asserted that “any lay person can easily grasp the concept that a person dies from losing so much blood that multiple organs fail to perform their functions.” Mr. Barbee’s death thus was not “of such a technical nature that lay persons are incompetent to draw their own conclusions from facts presented without aid.”

Hawaii’s Intermediate Court of Appeals disagreed with the plaintiffs, holding that although “Hawaii does recognize a ‘common knowledge’ exception to the requirement that a plaintiff must introduce expert medical testimony on causation … this exception is rare in application.” The court asserted that the causal link between any alleged negligence and Mr. Barbee’s death 17 months later is not within the realm of common knowledge.

It reasoned that the long-term effects of internal bleeding are not so widely known as to be analogous to leaving a sponge within a patient or removing the wrong limb during an amputation. Moreover, Mr. Barbee had a long history of preexisting conditions, including hypertension, diabetes, and cancer. He also suffered numerous and serious postoperative medical conditions, including a stroke and surgery to remove part of his intestine, which had become gangrenous.

Thus, the role that preexisting conditions and/or the subsequent complications of this type played in Mr. Barbee’s death was not within the knowledge of the average layperson.

The “common knowledge” rule is aligned with, though not identical to, the res doctrine, but courts are known to conflate the two legal principles, often using them interchangeably.4

Strictly speaking, the “common knowledge” waiver comes into play where direct evidence of negligent conduct lies within the realm of everyday lay knowledge that the physician had deviated from common practice. It may or may not address the causation issue.

On the other hand, res is successfully invoked when, despite no direct evidence of negligence and causation, the circumstances surrounding the injury are such that the plaintiff’s case can go to the jury without expert testimony.

References

1. Ybarra v. Spangard, 154 P.2d 687 (Cal. 1944).

2. James v. Wormuth, 997 N.E.2d 133 (N.Y. 2013).

3. Barbee v. Queen’s Medical Center, 119 Haw 136 (2008).

4. Spinner, Amanda E. Common Ignorance: Medical Malpractice Law and the Misconceived Application of the “Common Knowledge” and “Res Ipsa Loquitur” Doctrines.” Touro Law Review: Vol. 31: No. 3, Article 15. Available at http://digitalcommons.tourolaw.edu/lawreview/vol31/iss3/15.

Dr. Tan is professor emeritus of medicine and former adjunct professor of law at the University of Hawaii, and currently directs the St. Francis International Center for Healthcare Ethics in Honolulu. This article is meant to be educational and does not constitute medical, ethical, or legal advice. Some of the articles in this series are adapted from the author’s 2006 book, “Medical Malpractice: Understanding the Law, Managing the Risk,” and his 2012 Halsbury treatise, “Medical Negligence and Professional Misconduct.” For additional information, readers may contact the author at [email protected].

References

References

Publications
Publications
Topics
Article Type
Display Headline
Dispensing with expert testimony
Display Headline
Dispensing with expert testimony
Legacy Keywords
malpractice, expert witness, expert testimony, medical negligence
Legacy Keywords
malpractice, expert witness, expert testimony, medical negligence
Sections
Article Source

PURLs Copyright

Inside the Article

The Power of Quiet

Article Type
Changed
Wed, 01/02/2019 - 09:33
Display Headline
The Power of Quiet

In his insightful book “The Wisdom of Crowds” (New York: Anchor Books, 2004), James Surowiecke makes the convincing argument that many heads are wiser than one, even if that one is the sole expert regarding the subject under discussion. As long as the decision-making group is diverse, with each individual being allowed to come to an independent conclusion, this tenet appears to hold, whether the group is estimating the number of jelly beans in a jar or resolving a difficult issue. The message is clear: As a leader your leadership will be more effective if you solicit input from all members of your group, including those who may be reluctant to offer it.

In another excellent book, “Quiet” (New York: Crown Publishers, 2012), Susan Cain posits that, from early in the 20th century on, despite the considerable value it has to offer, introversion has become a “second-class personality trait.” Although highly valued earlier in our history, the thoughtful, introspective temperament was replaced by the aggressive, decisive character as the ideal.

 

Dr. Layton F. Rikkers
Emblematic of the shift that was taking place in American culture was the publication in 1936 of one of the first self-help books, “How to Win Friends and Influence People” (Dale Carnegie, New York: Simon and Schuster, 1936), which extolled the virtues of an outgoing, dominant personality. That a gregarious, sociable person was more likely to find success than a quiet, contemplative one became a part of common knowledge. The shift was so extreme that many parents became concerned when they detected shyness in their child and often attempted to correct what was thought by many to be an inferior personality trait.

Cain delves deeply into the substantial differences between extroverts and introverts, acknowledging that there are many gradations between the extremes. Extroverts tend to be loquacious and are seldom hesitant to offer their opinions on complex, difficult issues, even when their understanding of them is limited. They don’t always think before speaking and are less skilled listeners than introverts. They prefer to come to decisions rapidly, sometimes with incomplete data, and are much more decisive than introverts.

Introverts, on the other hand, prefer to listen rather than talk and to thoroughly vet an issue before reaching a decision. When they do, they are uncomfortable expressing it in a group setting. They prefer to work alone rather than in groups and, because of their thoughtful approach, their solutions to problems may be more innovative and sound than the shoot-from-the-hip, rapid answers that extroverts frequently propose. They abhor conflict and are likely to remain silent during controversy. In sum, although more difficult to elicit, obtaining input from the quiet members of the group is very worthwhile.

Often the most timely and ideal resolution is reached by balanced contributions from both personality types, the decision-making extroverts and the more thoughtful but reticent introverts. In fact, some of the best team members are those who are not on either extreme of the extrovert-introvert scale. But considering the fact that one-third to one-half of Americans are introverts (I suspect the fraction is a bit less among surgeons) and hesitant to offer their opinions in a group setting, how is this to be accomplished?

First, as a leader, you need to be sensitive to the fact that the introverts in your group are likely out of their comfort zone during communal meetings. It may even be embarrassing for them if they are called upon to offer their advice or opinion. To some degree this reluctance can be overcome by a leader who always attempts to reach consensus by valuing everyone’s opinion. Even the arrangement of the meeting room is important. The ideal is for all participants to be situated around a table rather than facing an imposing leader at the front of the room. This “leveling of the play field” emphasizes equality, de-emphasizes hierarchy, and encourages all to participate. The least likely to contribute can often be nudged from their quiet solitude by gentle urging from the leader with a statement such as: “Joe, I know you have a thoughtful perspective on this. Can you share it with the group?”

However, even the best-run meeting may not result in satisfactory resolution of difficult issues. In my experience, even those toward the extrovert end of the spectrum may be hesitant to offer their honest opinion in a meeting if it is in conflict with that of the leader. It is not uncommon to come to a consensus resolution of a controversial issue in a group meeting only to find out from hallway chatter that many disagree with the agreement reached. It is essential that the leader have access to this hallway chatter. This can be accomplished by way of confidantes who have the trust of both the troops and the leader.

 

 

During my years of leadership, a useful and productive technique I fostered to prompt input from introverts and honest assessments from all was to visit individual offices after the busy work day had quieted down, usually after 5 p.m. Meeting with individual faculty in their offices rather than in mine lent an informality to the conversation that could not be duplicated in the office of the chairman. In these one-on-one encounters, I found that even my relatively quiet faculty members felt comfortable in expressing their views regarding controversial issues facing our department. These informal chats also allowed me to become aware of problems they were facing in their professional and personal lives. They were great opportunities for mentoring and bonding as well. When these individual discussions precede what is anticipated to be a contentious group meeting, the likelihood of a successful conclusion is significantly enhanced.

Although my leadership experience was confined within the walls of academe, I believe these principles apply to anyone invited to lead a group in virtually any setting. Individual meetings are not an efficient way to lead, but they may provide a more effective and, in some cases, more rapid means of reaching consensus than innumerable group meetings with follow-up emails. When the group is too large to conference with everyone individually, one-on-one meetings with several key players may achieve the same result. During the process, don’t forget the quiet ones. They sometimes contribute the best and most innovative solutions to complex problems. There is power in quiet.

 

Dr. Rikkers is Editor in Chief of ACS Surgery News.

Publications
Sections

In his insightful book “The Wisdom of Crowds” (New York: Anchor Books, 2004), James Surowiecke makes the convincing argument that many heads are wiser than one, even if that one is the sole expert regarding the subject under discussion. As long as the decision-making group is diverse, with each individual being allowed to come to an independent conclusion, this tenet appears to hold, whether the group is estimating the number of jelly beans in a jar or resolving a difficult issue. The message is clear: As a leader your leadership will be more effective if you solicit input from all members of your group, including those who may be reluctant to offer it.

In another excellent book, “Quiet” (New York: Crown Publishers, 2012), Susan Cain posits that, from early in the 20th century on, despite the considerable value it has to offer, introversion has become a “second-class personality trait.” Although highly valued earlier in our history, the thoughtful, introspective temperament was replaced by the aggressive, decisive character as the ideal.

 

Dr. Layton F. Rikkers
Emblematic of the shift that was taking place in American culture was the publication in 1936 of one of the first self-help books, “How to Win Friends and Influence People” (Dale Carnegie, New York: Simon and Schuster, 1936), which extolled the virtues of an outgoing, dominant personality. That a gregarious, sociable person was more likely to find success than a quiet, contemplative one became a part of common knowledge. The shift was so extreme that many parents became concerned when they detected shyness in their child and often attempted to correct what was thought by many to be an inferior personality trait.

Cain delves deeply into the substantial differences between extroverts and introverts, acknowledging that there are many gradations between the extremes. Extroverts tend to be loquacious and are seldom hesitant to offer their opinions on complex, difficult issues, even when their understanding of them is limited. They don’t always think before speaking and are less skilled listeners than introverts. They prefer to come to decisions rapidly, sometimes with incomplete data, and are much more decisive than introverts.

Introverts, on the other hand, prefer to listen rather than talk and to thoroughly vet an issue before reaching a decision. When they do, they are uncomfortable expressing it in a group setting. They prefer to work alone rather than in groups and, because of their thoughtful approach, their solutions to problems may be more innovative and sound than the shoot-from-the-hip, rapid answers that extroverts frequently propose. They abhor conflict and are likely to remain silent during controversy. In sum, although more difficult to elicit, obtaining input from the quiet members of the group is very worthwhile.

Often the most timely and ideal resolution is reached by balanced contributions from both personality types, the decision-making extroverts and the more thoughtful but reticent introverts. In fact, some of the best team members are those who are not on either extreme of the extrovert-introvert scale. But considering the fact that one-third to one-half of Americans are introverts (I suspect the fraction is a bit less among surgeons) and hesitant to offer their opinions in a group setting, how is this to be accomplished?

First, as a leader, you need to be sensitive to the fact that the introverts in your group are likely out of their comfort zone during communal meetings. It may even be embarrassing for them if they are called upon to offer their advice or opinion. To some degree this reluctance can be overcome by a leader who always attempts to reach consensus by valuing everyone’s opinion. Even the arrangement of the meeting room is important. The ideal is for all participants to be situated around a table rather than facing an imposing leader at the front of the room. This “leveling of the play field” emphasizes equality, de-emphasizes hierarchy, and encourages all to participate. The least likely to contribute can often be nudged from their quiet solitude by gentle urging from the leader with a statement such as: “Joe, I know you have a thoughtful perspective on this. Can you share it with the group?”

However, even the best-run meeting may not result in satisfactory resolution of difficult issues. In my experience, even those toward the extrovert end of the spectrum may be hesitant to offer their honest opinion in a meeting if it is in conflict with that of the leader. It is not uncommon to come to a consensus resolution of a controversial issue in a group meeting only to find out from hallway chatter that many disagree with the agreement reached. It is essential that the leader have access to this hallway chatter. This can be accomplished by way of confidantes who have the trust of both the troops and the leader.

 

 

During my years of leadership, a useful and productive technique I fostered to prompt input from introverts and honest assessments from all was to visit individual offices after the busy work day had quieted down, usually after 5 p.m. Meeting with individual faculty in their offices rather than in mine lent an informality to the conversation that could not be duplicated in the office of the chairman. In these one-on-one encounters, I found that even my relatively quiet faculty members felt comfortable in expressing their views regarding controversial issues facing our department. These informal chats also allowed me to become aware of problems they were facing in their professional and personal lives. They were great opportunities for mentoring and bonding as well. When these individual discussions precede what is anticipated to be a contentious group meeting, the likelihood of a successful conclusion is significantly enhanced.

Although my leadership experience was confined within the walls of academe, I believe these principles apply to anyone invited to lead a group in virtually any setting. Individual meetings are not an efficient way to lead, but they may provide a more effective and, in some cases, more rapid means of reaching consensus than innumerable group meetings with follow-up emails. When the group is too large to conference with everyone individually, one-on-one meetings with several key players may achieve the same result. During the process, don’t forget the quiet ones. They sometimes contribute the best and most innovative solutions to complex problems. There is power in quiet.

 

Dr. Rikkers is Editor in Chief of ACS Surgery News.

In his insightful book “The Wisdom of Crowds” (New York: Anchor Books, 2004), James Surowiecke makes the convincing argument that many heads are wiser than one, even if that one is the sole expert regarding the subject under discussion. As long as the decision-making group is diverse, with each individual being allowed to come to an independent conclusion, this tenet appears to hold, whether the group is estimating the number of jelly beans in a jar or resolving a difficult issue. The message is clear: As a leader your leadership will be more effective if you solicit input from all members of your group, including those who may be reluctant to offer it.

In another excellent book, “Quiet” (New York: Crown Publishers, 2012), Susan Cain posits that, from early in the 20th century on, despite the considerable value it has to offer, introversion has become a “second-class personality trait.” Although highly valued earlier in our history, the thoughtful, introspective temperament was replaced by the aggressive, decisive character as the ideal.

 

Dr. Layton F. Rikkers
Emblematic of the shift that was taking place in American culture was the publication in 1936 of one of the first self-help books, “How to Win Friends and Influence People” (Dale Carnegie, New York: Simon and Schuster, 1936), which extolled the virtues of an outgoing, dominant personality. That a gregarious, sociable person was more likely to find success than a quiet, contemplative one became a part of common knowledge. The shift was so extreme that many parents became concerned when they detected shyness in their child and often attempted to correct what was thought by many to be an inferior personality trait.

Cain delves deeply into the substantial differences between extroverts and introverts, acknowledging that there are many gradations between the extremes. Extroverts tend to be loquacious and are seldom hesitant to offer their opinions on complex, difficult issues, even when their understanding of them is limited. They don’t always think before speaking and are less skilled listeners than introverts. They prefer to come to decisions rapidly, sometimes with incomplete data, and are much more decisive than introverts.

Introverts, on the other hand, prefer to listen rather than talk and to thoroughly vet an issue before reaching a decision. When they do, they are uncomfortable expressing it in a group setting. They prefer to work alone rather than in groups and, because of their thoughtful approach, their solutions to problems may be more innovative and sound than the shoot-from-the-hip, rapid answers that extroverts frequently propose. They abhor conflict and are likely to remain silent during controversy. In sum, although more difficult to elicit, obtaining input from the quiet members of the group is very worthwhile.

Often the most timely and ideal resolution is reached by balanced contributions from both personality types, the decision-making extroverts and the more thoughtful but reticent introverts. In fact, some of the best team members are those who are not on either extreme of the extrovert-introvert scale. But considering the fact that one-third to one-half of Americans are introverts (I suspect the fraction is a bit less among surgeons) and hesitant to offer their opinions in a group setting, how is this to be accomplished?

First, as a leader, you need to be sensitive to the fact that the introverts in your group are likely out of their comfort zone during communal meetings. It may even be embarrassing for them if they are called upon to offer their advice or opinion. To some degree this reluctance can be overcome by a leader who always attempts to reach consensus by valuing everyone’s opinion. Even the arrangement of the meeting room is important. The ideal is for all participants to be situated around a table rather than facing an imposing leader at the front of the room. This “leveling of the play field” emphasizes equality, de-emphasizes hierarchy, and encourages all to participate. The least likely to contribute can often be nudged from their quiet solitude by gentle urging from the leader with a statement such as: “Joe, I know you have a thoughtful perspective on this. Can you share it with the group?”

However, even the best-run meeting may not result in satisfactory resolution of difficult issues. In my experience, even those toward the extrovert end of the spectrum may be hesitant to offer their honest opinion in a meeting if it is in conflict with that of the leader. It is not uncommon to come to a consensus resolution of a controversial issue in a group meeting only to find out from hallway chatter that many disagree with the agreement reached. It is essential that the leader have access to this hallway chatter. This can be accomplished by way of confidantes who have the trust of both the troops and the leader.

 

 

During my years of leadership, a useful and productive technique I fostered to prompt input from introverts and honest assessments from all was to visit individual offices after the busy work day had quieted down, usually after 5 p.m. Meeting with individual faculty in their offices rather than in mine lent an informality to the conversation that could not be duplicated in the office of the chairman. In these one-on-one encounters, I found that even my relatively quiet faculty members felt comfortable in expressing their views regarding controversial issues facing our department. These informal chats also allowed me to become aware of problems they were facing in their professional and personal lives. They were great opportunities for mentoring and bonding as well. When these individual discussions precede what is anticipated to be a contentious group meeting, the likelihood of a successful conclusion is significantly enhanced.

Although my leadership experience was confined within the walls of academe, I believe these principles apply to anyone invited to lead a group in virtually any setting. Individual meetings are not an efficient way to lead, but they may provide a more effective and, in some cases, more rapid means of reaching consensus than innumerable group meetings with follow-up emails. When the group is too large to conference with everyone individually, one-on-one meetings with several key players may achieve the same result. During the process, don’t forget the quiet ones. They sometimes contribute the best and most innovative solutions to complex problems. There is power in quiet.

 

Dr. Rikkers is Editor in Chief of ACS Surgery News.

Publications
Publications
Article Type
Display Headline
The Power of Quiet
Display Headline
The Power of Quiet
Sections
Disallow All Ads

From the Washington Office: A guide to in-district meetings with your representatives and senators

Article Type
Changed
Wed, 01/02/2019 - 09:31
Display Headline
From the Washington Office: A guide to in-district meetings with your representatives and senators

WHY should surgeons take time out of their busy schedules to meet with legislators?

To become an effective surgeon advocate, nothing is more important than establishing a personal relationship with your legislators. Conversely, to a legislator, there is nothing more valuable than the input and support of constituents. After all, constituents are VOTERS. Meeting with policy makers and/or their staff is extremely valuable in advancing the overall advocacy agenda of The American College of Surgeons and provides surgeons with the opportunity to develop key contacts in the offices of their legislators.

WHERE do such meetings take place?

All U.S. Representatives and Senators have one or more offices for constituent service in their home districts or states. These offices serve as a readily accessible meeting point. As an alternative, legislators frequently will schedule meetings with constituents in mutually convenient locations such as a coffee shop, or during a local legislative event such as a town hall.

Dr. Patrick V. Bailey

WHEN is it most feasible to schedule in-district meetings?

You might be surprised to discover how much time is allotted by both the House and Senate for in-district work periods. Typical times include periods around President’s Day in February, Easter/Passover in March/April, Memorial Day, Independence Day, and summer recess (late July and the month of August). If Congress does not officially adjourn in early October, additional work periods include time around Columbus Day in October, Veteran’s Day in November, and Thanksgiving. Congress will usually adjourn for the year in December. A specific schedule for each legislative body for the year 2016 can be found at:

House of Representatives: http://www.majorityleader.gov/wp-content/uploads/2011/07/2016_ANNUAL_CALENDAR.pdf

Senate: http://www.senate.gov/legislative/resources/pdf/2016_calendar.pdf

HOW does one schedule an in-district meeting?

To set up a meeting you should first search the websites of your representatives (www.house.gov) and senators (www.senate.gov) for information as to the preferred scheduling procedures. Expect each office’s procedure to be a bit different. You will be asked to provide your name, address, and basic contact information as well as to briefly describe what issue(s) you wish to discuss. Be sure to mention that you are a surgeon and also whether you have previously met with the representative or senator.

If several days pass and staff from the office have not followed up, you should not hesitate to call or contact the office again. Remember, persistence is key! Keep in mind that legislators typically maintain busy schedules during the in-district work period and accordingly, the scheduled appointment time will be brief and subject to change, perhaps on short notice.

If you experience difficulty or simply would like to have assistance in scheduling an in-district meeting, staff in the ACS Division of Advocacy and Health Policy are available to assist and may be contacted by e-mail at surgeonsvoice.org.

WHAT should one discuss?

As a surgeon advocate, your most powerful tool is frequent contact and meetings with your elected officials. Meetings provide an opportunity to offer knowledge and perspective to educate legislators on key topics important to ensuring access to quality surgical care. Your personal experience brings a personal, human touch to issues about which legislators only have knowledge based upon raw numbers and impersonal policy jargon. Most legislators, as well as their staff, will be grateful to have the reliable resource of a constituent’s experience and perspective on complicated medical issues.

To maximize the opportunity for a successful meeting and thereby lay the foundation for the development of a mutually beneficial future relationship, I would offer the following three tips:

1) KNOW YOUR LEGISLATOR: Visit your legislators’ websites, read their biographies, ascertain to what congressional committees they are assigned, and what leadership roles they may have. All of this serves to help determine what issues are important to them and what positions they have previously taken on such issues.

2) KNOW YOUR ISSUE and be able to FRAME IT: Nothing substitutes for a solid knowledge base of the issue and the position you are trying to convey. Be focused and resist the temptation to try to cover too many topics in any one visit. When presenting your argument, “frame it” in layman’s terms much as you would explain it to a patient. Including examples of real-life, anecdotal experiences demonstrating how the status quo or the proposed legislation (depending upon the circumstance) is impacting providers and patients is particularly important.

3) HAVE AN ASK: It is imperative that you always be clear with your legislators about what you want them to do. This serves to reinforce the importance of your having taken time out of your schedule to communicate with them and also serves to hold the legislator accountable. “Asks” can be as specific as a request to cosponsor and support legislation or simply making the offer to serve as a resource to them as a constituent with expertise in health care.

 

 

Lastly, I would respectfully request that when surgeons meet with their legislators they inform the ACS Division of Advocacy and Health Policy. Having basic information about the outcome of the meeting, whether knowing that the legislator committed to taking a specific action or knowing that the legislator has requested additional information, is incredibly valuable to us in our ongoing advocacy efforts on behalf of surgeons and their patients here in Washington, DC.

Until next month ….

Dr. Patrick V. Bailey is an ACS Fellow, a pediatric surgeon, and Medical Director, Advocacy, for the Division of Advocacy and Health Policy, in the ACS offices in Washington, D.C.

References

Author and Disclosure Information

Publications
Sections
Author and Disclosure Information

Author and Disclosure Information

WHY should surgeons take time out of their busy schedules to meet with legislators?

To become an effective surgeon advocate, nothing is more important than establishing a personal relationship with your legislators. Conversely, to a legislator, there is nothing more valuable than the input and support of constituents. After all, constituents are VOTERS. Meeting with policy makers and/or their staff is extremely valuable in advancing the overall advocacy agenda of The American College of Surgeons and provides surgeons with the opportunity to develop key contacts in the offices of their legislators.

WHERE do such meetings take place?

All U.S. Representatives and Senators have one or more offices for constituent service in their home districts or states. These offices serve as a readily accessible meeting point. As an alternative, legislators frequently will schedule meetings with constituents in mutually convenient locations such as a coffee shop, or during a local legislative event such as a town hall.

Dr. Patrick V. Bailey

WHEN is it most feasible to schedule in-district meetings?

You might be surprised to discover how much time is allotted by both the House and Senate for in-district work periods. Typical times include periods around President’s Day in February, Easter/Passover in March/April, Memorial Day, Independence Day, and summer recess (late July and the month of August). If Congress does not officially adjourn in early October, additional work periods include time around Columbus Day in October, Veteran’s Day in November, and Thanksgiving. Congress will usually adjourn for the year in December. A specific schedule for each legislative body for the year 2016 can be found at:

House of Representatives: http://www.majorityleader.gov/wp-content/uploads/2011/07/2016_ANNUAL_CALENDAR.pdf

Senate: http://www.senate.gov/legislative/resources/pdf/2016_calendar.pdf

HOW does one schedule an in-district meeting?

To set up a meeting you should first search the websites of your representatives (www.house.gov) and senators (www.senate.gov) for information as to the preferred scheduling procedures. Expect each office’s procedure to be a bit different. You will be asked to provide your name, address, and basic contact information as well as to briefly describe what issue(s) you wish to discuss. Be sure to mention that you are a surgeon and also whether you have previously met with the representative or senator.

If several days pass and staff from the office have not followed up, you should not hesitate to call or contact the office again. Remember, persistence is key! Keep in mind that legislators typically maintain busy schedules during the in-district work period and accordingly, the scheduled appointment time will be brief and subject to change, perhaps on short notice.

If you experience difficulty or simply would like to have assistance in scheduling an in-district meeting, staff in the ACS Division of Advocacy and Health Policy are available to assist and may be contacted by e-mail at surgeonsvoice.org.

WHAT should one discuss?

As a surgeon advocate, your most powerful tool is frequent contact and meetings with your elected officials. Meetings provide an opportunity to offer knowledge and perspective to educate legislators on key topics important to ensuring access to quality surgical care. Your personal experience brings a personal, human touch to issues about which legislators only have knowledge based upon raw numbers and impersonal policy jargon. Most legislators, as well as their staff, will be grateful to have the reliable resource of a constituent’s experience and perspective on complicated medical issues.

To maximize the opportunity for a successful meeting and thereby lay the foundation for the development of a mutually beneficial future relationship, I would offer the following three tips:

1) KNOW YOUR LEGISLATOR: Visit your legislators’ websites, read their biographies, ascertain to what congressional committees they are assigned, and what leadership roles they may have. All of this serves to help determine what issues are important to them and what positions they have previously taken on such issues.

2) KNOW YOUR ISSUE and be able to FRAME IT: Nothing substitutes for a solid knowledge base of the issue and the position you are trying to convey. Be focused and resist the temptation to try to cover too many topics in any one visit. When presenting your argument, “frame it” in layman’s terms much as you would explain it to a patient. Including examples of real-life, anecdotal experiences demonstrating how the status quo or the proposed legislation (depending upon the circumstance) is impacting providers and patients is particularly important.

3) HAVE AN ASK: It is imperative that you always be clear with your legislators about what you want them to do. This serves to reinforce the importance of your having taken time out of your schedule to communicate with them and also serves to hold the legislator accountable. “Asks” can be as specific as a request to cosponsor and support legislation or simply making the offer to serve as a resource to them as a constituent with expertise in health care.

 

 

Lastly, I would respectfully request that when surgeons meet with their legislators they inform the ACS Division of Advocacy and Health Policy. Having basic information about the outcome of the meeting, whether knowing that the legislator committed to taking a specific action or knowing that the legislator has requested additional information, is incredibly valuable to us in our ongoing advocacy efforts on behalf of surgeons and their patients here in Washington, DC.

Until next month ….

Dr. Patrick V. Bailey is an ACS Fellow, a pediatric surgeon, and Medical Director, Advocacy, for the Division of Advocacy and Health Policy, in the ACS offices in Washington, D.C.

WHY should surgeons take time out of their busy schedules to meet with legislators?

To become an effective surgeon advocate, nothing is more important than establishing a personal relationship with your legislators. Conversely, to a legislator, there is nothing more valuable than the input and support of constituents. After all, constituents are VOTERS. Meeting with policy makers and/or their staff is extremely valuable in advancing the overall advocacy agenda of The American College of Surgeons and provides surgeons with the opportunity to develop key contacts in the offices of their legislators.

WHERE do such meetings take place?

All U.S. Representatives and Senators have one or more offices for constituent service in their home districts or states. These offices serve as a readily accessible meeting point. As an alternative, legislators frequently will schedule meetings with constituents in mutually convenient locations such as a coffee shop, or during a local legislative event such as a town hall.

Dr. Patrick V. Bailey

WHEN is it most feasible to schedule in-district meetings?

You might be surprised to discover how much time is allotted by both the House and Senate for in-district work periods. Typical times include periods around President’s Day in February, Easter/Passover in March/April, Memorial Day, Independence Day, and summer recess (late July and the month of August). If Congress does not officially adjourn in early October, additional work periods include time around Columbus Day in October, Veteran’s Day in November, and Thanksgiving. Congress will usually adjourn for the year in December. A specific schedule for each legislative body for the year 2016 can be found at:

House of Representatives: http://www.majorityleader.gov/wp-content/uploads/2011/07/2016_ANNUAL_CALENDAR.pdf

Senate: http://www.senate.gov/legislative/resources/pdf/2016_calendar.pdf

HOW does one schedule an in-district meeting?

To set up a meeting you should first search the websites of your representatives (www.house.gov) and senators (www.senate.gov) for information as to the preferred scheduling procedures. Expect each office’s procedure to be a bit different. You will be asked to provide your name, address, and basic contact information as well as to briefly describe what issue(s) you wish to discuss. Be sure to mention that you are a surgeon and also whether you have previously met with the representative or senator.

If several days pass and staff from the office have not followed up, you should not hesitate to call or contact the office again. Remember, persistence is key! Keep in mind that legislators typically maintain busy schedules during the in-district work period and accordingly, the scheduled appointment time will be brief and subject to change, perhaps on short notice.

If you experience difficulty or simply would like to have assistance in scheduling an in-district meeting, staff in the ACS Division of Advocacy and Health Policy are available to assist and may be contacted by e-mail at surgeonsvoice.org.

WHAT should one discuss?

As a surgeon advocate, your most powerful tool is frequent contact and meetings with your elected officials. Meetings provide an opportunity to offer knowledge and perspective to educate legislators on key topics important to ensuring access to quality surgical care. Your personal experience brings a personal, human touch to issues about which legislators only have knowledge based upon raw numbers and impersonal policy jargon. Most legislators, as well as their staff, will be grateful to have the reliable resource of a constituent’s experience and perspective on complicated medical issues.

To maximize the opportunity for a successful meeting and thereby lay the foundation for the development of a mutually beneficial future relationship, I would offer the following three tips:

1) KNOW YOUR LEGISLATOR: Visit your legislators’ websites, read their biographies, ascertain to what congressional committees they are assigned, and what leadership roles they may have. All of this serves to help determine what issues are important to them and what positions they have previously taken on such issues.

2) KNOW YOUR ISSUE and be able to FRAME IT: Nothing substitutes for a solid knowledge base of the issue and the position you are trying to convey. Be focused and resist the temptation to try to cover too many topics in any one visit. When presenting your argument, “frame it” in layman’s terms much as you would explain it to a patient. Including examples of real-life, anecdotal experiences demonstrating how the status quo or the proposed legislation (depending upon the circumstance) is impacting providers and patients is particularly important.

3) HAVE AN ASK: It is imperative that you always be clear with your legislators about what you want them to do. This serves to reinforce the importance of your having taken time out of your schedule to communicate with them and also serves to hold the legislator accountable. “Asks” can be as specific as a request to cosponsor and support legislation or simply making the offer to serve as a resource to them as a constituent with expertise in health care.

 

 

Lastly, I would respectfully request that when surgeons meet with their legislators they inform the ACS Division of Advocacy and Health Policy. Having basic information about the outcome of the meeting, whether knowing that the legislator committed to taking a specific action or knowing that the legislator has requested additional information, is incredibly valuable to us in our ongoing advocacy efforts on behalf of surgeons and their patients here in Washington, DC.

Until next month ….

Dr. Patrick V. Bailey is an ACS Fellow, a pediatric surgeon, and Medical Director, Advocacy, for the Division of Advocacy and Health Policy, in the ACS offices in Washington, D.C.

References

References

Publications
Publications
Article Type
Display Headline
From the Washington Office: A guide to in-district meetings with your representatives and senators
Display Headline
From the Washington Office: A guide to in-district meetings with your representatives and senators
Sections
Article Source

PURLs Copyright

Inside the Article

Conflicts in the physician-patient relationship

Article Type
Changed
Thu, 12/06/2018 - 11:26
Display Headline
Conflicts in the physician-patient relationship

The basic premise of the physician-patient relationship is simple: Patients are ill and we want to make them better. But the true nature of the relationship is not so monochromatic. Patients and physicians can differ, either on what ails the patient or on what will make the patient better, and it can be challenging to navigate that divide.

One common source of conflict for me is test ordering. I tend to be somewhat conservative when it comes to ordering tests, but patients will often feel shortchanged if they are not subjected to needlesticks and radiation. One of the most common requests I get, being in New England, is for Lyme testing. Patients have gotten so sophisticated now that they expect a Western blot. “My primary care doc just refuses to order a Western blot for me,” one lady complained.

Dr. Karmela K. Chan

Settling on a mutually acceptable diagnosis can be tricky as well. Of course, “mutually acceptable” is not the issue: a patient either has a diagnosis or does not. But in order for the patient to accept your recommended therapy, they have to believe that you have the right diagnosis. And some diagnoses are hard to accept and even harder to prove than others. A few patients refuse to believe that they have rheumatoid arthritis, particularly if they test negative. And how many of your patients refuse to believe that they have fibromyalgia? How many insist that they have that catch-all, “autoimmune disease,” despite evidence to the contrary?

On the matter of treatment, there are disagreements, too. The most obvious example, and one of the biggest challenges, is narcotic prescription. Patients with chronic pain often rely on narcotics to feel better, but narcotic use is not recommended in such patients. Physicians and patients can expect to be in a perennial tension over who prevails.

Mental health issues are the most challenging for me. For example, I have a young patient who has a polysubstance use disorder and gets admitted repeatedly for alcohol-induced pancreatitis, yet refuses to get mental health therapy for it despite multiple inpatient psychiatric consultations exhorting her to do so. “It doesn’t do anything for me,” she says. She lies about everything, from medication compliance to where she gets medications to how much she drinks, yet I do not feel equipped to handle these problems.

If any of the above scenarios were board exam questions, choosing the proverbial next best step would be simple. But when does life really operate so neatly? The old paradigm of doctoring was that the physician rendered an opinion informed by his or her education. Today, our exam-room interactions often take the shape of a democracy, one in which an overworked, bandwidth-depleted physician might butt heads with a strong-willed patient, armed with all the wisdom of anecdotes and the Internet. If I were fresh out of med school, I might have had more energy to explain to you why you don’t need that Lyme test or that narcotic prescription. These days though, I find myself waving the white flag far more than I should.

Dr. Chan practices rheumatology in Pawtucket, R.I.

References

Author and Disclosure Information

Publications
Sections
Author and Disclosure Information

Author and Disclosure Information

The basic premise of the physician-patient relationship is simple: Patients are ill and we want to make them better. But the true nature of the relationship is not so monochromatic. Patients and physicians can differ, either on what ails the patient or on what will make the patient better, and it can be challenging to navigate that divide.

One common source of conflict for me is test ordering. I tend to be somewhat conservative when it comes to ordering tests, but patients will often feel shortchanged if they are not subjected to needlesticks and radiation. One of the most common requests I get, being in New England, is for Lyme testing. Patients have gotten so sophisticated now that they expect a Western blot. “My primary care doc just refuses to order a Western blot for me,” one lady complained.

Dr. Karmela K. Chan

Settling on a mutually acceptable diagnosis can be tricky as well. Of course, “mutually acceptable” is not the issue: a patient either has a diagnosis or does not. But in order for the patient to accept your recommended therapy, they have to believe that you have the right diagnosis. And some diagnoses are hard to accept and even harder to prove than others. A few patients refuse to believe that they have rheumatoid arthritis, particularly if they test negative. And how many of your patients refuse to believe that they have fibromyalgia? How many insist that they have that catch-all, “autoimmune disease,” despite evidence to the contrary?

On the matter of treatment, there are disagreements, too. The most obvious example, and one of the biggest challenges, is narcotic prescription. Patients with chronic pain often rely on narcotics to feel better, but narcotic use is not recommended in such patients. Physicians and patients can expect to be in a perennial tension over who prevails.

Mental health issues are the most challenging for me. For example, I have a young patient who has a polysubstance use disorder and gets admitted repeatedly for alcohol-induced pancreatitis, yet refuses to get mental health therapy for it despite multiple inpatient psychiatric consultations exhorting her to do so. “It doesn’t do anything for me,” she says. She lies about everything, from medication compliance to where she gets medications to how much she drinks, yet I do not feel equipped to handle these problems.

If any of the above scenarios were board exam questions, choosing the proverbial next best step would be simple. But when does life really operate so neatly? The old paradigm of doctoring was that the physician rendered an opinion informed by his or her education. Today, our exam-room interactions often take the shape of a democracy, one in which an overworked, bandwidth-depleted physician might butt heads with a strong-willed patient, armed with all the wisdom of anecdotes and the Internet. If I were fresh out of med school, I might have had more energy to explain to you why you don’t need that Lyme test or that narcotic prescription. These days though, I find myself waving the white flag far more than I should.

Dr. Chan practices rheumatology in Pawtucket, R.I.

The basic premise of the physician-patient relationship is simple: Patients are ill and we want to make them better. But the true nature of the relationship is not so monochromatic. Patients and physicians can differ, either on what ails the patient or on what will make the patient better, and it can be challenging to navigate that divide.

One common source of conflict for me is test ordering. I tend to be somewhat conservative when it comes to ordering tests, but patients will often feel shortchanged if they are not subjected to needlesticks and radiation. One of the most common requests I get, being in New England, is for Lyme testing. Patients have gotten so sophisticated now that they expect a Western blot. “My primary care doc just refuses to order a Western blot for me,” one lady complained.

Dr. Karmela K. Chan

Settling on a mutually acceptable diagnosis can be tricky as well. Of course, “mutually acceptable” is not the issue: a patient either has a diagnosis or does not. But in order for the patient to accept your recommended therapy, they have to believe that you have the right diagnosis. And some diagnoses are hard to accept and even harder to prove than others. A few patients refuse to believe that they have rheumatoid arthritis, particularly if they test negative. And how many of your patients refuse to believe that they have fibromyalgia? How many insist that they have that catch-all, “autoimmune disease,” despite evidence to the contrary?

On the matter of treatment, there are disagreements, too. The most obvious example, and one of the biggest challenges, is narcotic prescription. Patients with chronic pain often rely on narcotics to feel better, but narcotic use is not recommended in such patients. Physicians and patients can expect to be in a perennial tension over who prevails.

Mental health issues are the most challenging for me. For example, I have a young patient who has a polysubstance use disorder and gets admitted repeatedly for alcohol-induced pancreatitis, yet refuses to get mental health therapy for it despite multiple inpatient psychiatric consultations exhorting her to do so. “It doesn’t do anything for me,” she says. She lies about everything, from medication compliance to where she gets medications to how much she drinks, yet I do not feel equipped to handle these problems.

If any of the above scenarios were board exam questions, choosing the proverbial next best step would be simple. But when does life really operate so neatly? The old paradigm of doctoring was that the physician rendered an opinion informed by his or her education. Today, our exam-room interactions often take the shape of a democracy, one in which an overworked, bandwidth-depleted physician might butt heads with a strong-willed patient, armed with all the wisdom of anecdotes and the Internet. If I were fresh out of med school, I might have had more energy to explain to you why you don’t need that Lyme test or that narcotic prescription. These days though, I find myself waving the white flag far more than I should.

Dr. Chan practices rheumatology in Pawtucket, R.I.

References

References

Publications
Publications
Article Type
Display Headline
Conflicts in the physician-patient relationship
Display Headline
Conflicts in the physician-patient relationship
Sections
Article Source

PURLs Copyright

Inside the Article

CASE REPORTS: Transient neutrophilia in acute mania

Article Type
Changed
Wed, 12/12/2018 - 20:47
Display Headline
CASE REPORTS: Transient neutrophilia in acute mania

A description of two bipolar I disorder cases presents examples of the phenomenon of transient neutrophilia that occurred during admission into a state psychiatric hospital. A brief review of the mechanisms that may explain this hematologic response is included.

Background

Dr. Tim C. Taylor

In 1889, the U.S. territory of New Mexico established the New Mexico Insane Asylum, and it was known as such until 1955, when it became the State Hospital. In 1970, it became the Las Vegas Medical Center but changed its name in 2005 to the New Mexico Behavioral Health Institute (NMBHI), which services the entire state for inpatient and long-term care patients. On average, it accepts two admissions per day, of which two patients per month present with neutrophilia (white blood cell [WBC] count greater than 11,000), which resolves after 1-4 days in the hospital.

Case presentations

Case one. A 21-year-old Native American man presented with multiple psychiatric admissions for bipolar I disorder and major depression with suicidal ideation. He was brought into the local emergency department by police, who found him walking down the interstate highway trying to hitch a ride back to his native pueblo after a disagreement with a fellow resident at a local boarding home. He had discontinued his Seroquel and lithium 2 weeks earlier because he felt he no longer needed them and required medical clearance for admission.1 His presenting hemogram in the ED was normal except for an elevated WBC count of 20,000. His vital signs were normal except for tachycardia of 110 beats per minute. On exam the patient demonstrated a flat affect and anxiety but other than mild ingrown toenails and tachycardia, there were no abnormal findings.

He received a chest x-ray and abdominal computed tomography scan that were both normal, and the patient was cleared for admission. He was cooperative with staff and restarted his lithium. A repeat WBC at day 5 was 9,700.

Case two. A 24-year-old white man with a history of bipolar I disorder and dependency on benzodiazepines and Ritalin was transferred from a distant county jail after 10 days of incarceration. He started screaming in his cell, praying, and perseverating that he “needed to kill himself,” which triggered his transfer to the NMBHI. His aggressive behavior upon arrival necessitated a transfer to the local ED for sedation and four-point restraints. He received Versed and Ativan IVP before allowing a blood collection, which revealed dehydration and a WBC count of 17,100. After 4 L of normal saline, his labs normalized with a WBC of 10,100, and he was admitted for a 7-day committal.

Discussion

Neutrophilia can result from granulocytes moving from pericapillary tissue margins into the circulating pool.2 It may occur in association with vigorous exercise, seizures, paroxysmal tachycardia, and adrenergic stress.3 The duration is fewer than 30 minutes and usually results in WBC counts of 15,000-20,000.4 Beta receptors on endothelial cells may mediate neutrophil adherence and release from marginal sites. A left shift is absent, because there is no change of the inflow of cells from the marrow.

In these two cases, a transient neutrophilia and tachycardia were observed. Neither case was febrile, and the platelet count remained normal. Both patients voluntarily stopped taking their lithium about 2 weeks before decompensating from bipolar I disorders. Stress was evident in both cases, one from walking on a cold December night after a disagreement, while the other patient in case two was highly agitated and aggressive requiring four-point restraints and intravenous sedation in the ED before admission to NMBHI. Past histories of psychiatric admissions were noted in both cases, and neither subject smoked tobacco – which can increase WBC by 25%-50% with the use of one-two packs per day, respectively.5

These two cases show that clinicians should consider stress in its many permutations to the long list of causes to explain elevated WBC, particularly in the ED. They also illustrate the power of antianxiety medications for some patients with acute mania who present to the ED.

References

1. J Emerg Med. 2012;43(5):866-70.

2. “Wintrobe’s Clinical Hematology,” Philadelphia: Lea & Febiger, 1981, p.1292.

3. “Diagnostic Hematology,” London: Springer, 2009, p. 324.

4. Gen Hosp Psychiatry. 2005;27(6):454-56.

5. Euro Heart J. 2003 Jul;24(14)1365-72.

Dr. Taylor is a staff physician affiliated with the New Mexico Behavioral Health Institute, New Mexico Department of Health, Santa Fe. He reports no financial disclosures or conflicts of interest. The author wishes to thank Dr. Dan Collins from the NMBHI for recommending that he research and write about this topic. In addition, document access was greatly aided by Lisa Apodaca and Mary Bunker, CNP, from the NMBHI, and Karen Ebler and Dr. Irwin Hoffman from Christus St. Vincent Hospital in Santa Fe. Finally, the following colleagues helped by proofreading the manuscript: Dr. Wendy Dimmette, Dr. Richard Nail, and Dr. Matt Streicherz. Eva Romero and Dr. Troy Jones provided useful historical documentation.

References

Author and Disclosure Information

Publications
Topics
Sections
Author and Disclosure Information

Author and Disclosure Information

A description of two bipolar I disorder cases presents examples of the phenomenon of transient neutrophilia that occurred during admission into a state psychiatric hospital. A brief review of the mechanisms that may explain this hematologic response is included.

Background

Dr. Tim C. Taylor

In 1889, the U.S. territory of New Mexico established the New Mexico Insane Asylum, and it was known as such until 1955, when it became the State Hospital. In 1970, it became the Las Vegas Medical Center but changed its name in 2005 to the New Mexico Behavioral Health Institute (NMBHI), which services the entire state for inpatient and long-term care patients. On average, it accepts two admissions per day, of which two patients per month present with neutrophilia (white blood cell [WBC] count greater than 11,000), which resolves after 1-4 days in the hospital.

Case presentations

Case one. A 21-year-old Native American man presented with multiple psychiatric admissions for bipolar I disorder and major depression with suicidal ideation. He was brought into the local emergency department by police, who found him walking down the interstate highway trying to hitch a ride back to his native pueblo after a disagreement with a fellow resident at a local boarding home. He had discontinued his Seroquel and lithium 2 weeks earlier because he felt he no longer needed them and required medical clearance for admission.1 His presenting hemogram in the ED was normal except for an elevated WBC count of 20,000. His vital signs were normal except for tachycardia of 110 beats per minute. On exam the patient demonstrated a flat affect and anxiety but other than mild ingrown toenails and tachycardia, there were no abnormal findings.

He received a chest x-ray and abdominal computed tomography scan that were both normal, and the patient was cleared for admission. He was cooperative with staff and restarted his lithium. A repeat WBC at day 5 was 9,700.

Case two. A 24-year-old white man with a history of bipolar I disorder and dependency on benzodiazepines and Ritalin was transferred from a distant county jail after 10 days of incarceration. He started screaming in his cell, praying, and perseverating that he “needed to kill himself,” which triggered his transfer to the NMBHI. His aggressive behavior upon arrival necessitated a transfer to the local ED for sedation and four-point restraints. He received Versed and Ativan IVP before allowing a blood collection, which revealed dehydration and a WBC count of 17,100. After 4 L of normal saline, his labs normalized with a WBC of 10,100, and he was admitted for a 7-day committal.

Discussion

Neutrophilia can result from granulocytes moving from pericapillary tissue margins into the circulating pool.2 It may occur in association with vigorous exercise, seizures, paroxysmal tachycardia, and adrenergic stress.3 The duration is fewer than 30 minutes and usually results in WBC counts of 15,000-20,000.4 Beta receptors on endothelial cells may mediate neutrophil adherence and release from marginal sites. A left shift is absent, because there is no change of the inflow of cells from the marrow.

In these two cases, a transient neutrophilia and tachycardia were observed. Neither case was febrile, and the platelet count remained normal. Both patients voluntarily stopped taking their lithium about 2 weeks before decompensating from bipolar I disorders. Stress was evident in both cases, one from walking on a cold December night after a disagreement, while the other patient in case two was highly agitated and aggressive requiring four-point restraints and intravenous sedation in the ED before admission to NMBHI. Past histories of psychiatric admissions were noted in both cases, and neither subject smoked tobacco – which can increase WBC by 25%-50% with the use of one-two packs per day, respectively.5

These two cases show that clinicians should consider stress in its many permutations to the long list of causes to explain elevated WBC, particularly in the ED. They also illustrate the power of antianxiety medications for some patients with acute mania who present to the ED.

References

1. J Emerg Med. 2012;43(5):866-70.

2. “Wintrobe’s Clinical Hematology,” Philadelphia: Lea & Febiger, 1981, p.1292.

3. “Diagnostic Hematology,” London: Springer, 2009, p. 324.

4. Gen Hosp Psychiatry. 2005;27(6):454-56.

5. Euro Heart J. 2003 Jul;24(14)1365-72.

Dr. Taylor is a staff physician affiliated with the New Mexico Behavioral Health Institute, New Mexico Department of Health, Santa Fe. He reports no financial disclosures or conflicts of interest. The author wishes to thank Dr. Dan Collins from the NMBHI for recommending that he research and write about this topic. In addition, document access was greatly aided by Lisa Apodaca and Mary Bunker, CNP, from the NMBHI, and Karen Ebler and Dr. Irwin Hoffman from Christus St. Vincent Hospital in Santa Fe. Finally, the following colleagues helped by proofreading the manuscript: Dr. Wendy Dimmette, Dr. Richard Nail, and Dr. Matt Streicherz. Eva Romero and Dr. Troy Jones provided useful historical documentation.

A description of two bipolar I disorder cases presents examples of the phenomenon of transient neutrophilia that occurred during admission into a state psychiatric hospital. A brief review of the mechanisms that may explain this hematologic response is included.

Background

Dr. Tim C. Taylor

In 1889, the U.S. territory of New Mexico established the New Mexico Insane Asylum, and it was known as such until 1955, when it became the State Hospital. In 1970, it became the Las Vegas Medical Center but changed its name in 2005 to the New Mexico Behavioral Health Institute (NMBHI), which services the entire state for inpatient and long-term care patients. On average, it accepts two admissions per day, of which two patients per month present with neutrophilia (white blood cell [WBC] count greater than 11,000), which resolves after 1-4 days in the hospital.

Case presentations

Case one. A 21-year-old Native American man presented with multiple psychiatric admissions for bipolar I disorder and major depression with suicidal ideation. He was brought into the local emergency department by police, who found him walking down the interstate highway trying to hitch a ride back to his native pueblo after a disagreement with a fellow resident at a local boarding home. He had discontinued his Seroquel and lithium 2 weeks earlier because he felt he no longer needed them and required medical clearance for admission.1 His presenting hemogram in the ED was normal except for an elevated WBC count of 20,000. His vital signs were normal except for tachycardia of 110 beats per minute. On exam the patient demonstrated a flat affect and anxiety but other than mild ingrown toenails and tachycardia, there were no abnormal findings.

He received a chest x-ray and abdominal computed tomography scan that were both normal, and the patient was cleared for admission. He was cooperative with staff and restarted his lithium. A repeat WBC at day 5 was 9,700.

Case two. A 24-year-old white man with a history of bipolar I disorder and dependency on benzodiazepines and Ritalin was transferred from a distant county jail after 10 days of incarceration. He started screaming in his cell, praying, and perseverating that he “needed to kill himself,” which triggered his transfer to the NMBHI. His aggressive behavior upon arrival necessitated a transfer to the local ED for sedation and four-point restraints. He received Versed and Ativan IVP before allowing a blood collection, which revealed dehydration and a WBC count of 17,100. After 4 L of normal saline, his labs normalized with a WBC of 10,100, and he was admitted for a 7-day committal.

Discussion

Neutrophilia can result from granulocytes moving from pericapillary tissue margins into the circulating pool.2 It may occur in association with vigorous exercise, seizures, paroxysmal tachycardia, and adrenergic stress.3 The duration is fewer than 30 minutes and usually results in WBC counts of 15,000-20,000.4 Beta receptors on endothelial cells may mediate neutrophil adherence and release from marginal sites. A left shift is absent, because there is no change of the inflow of cells from the marrow.

In these two cases, a transient neutrophilia and tachycardia were observed. Neither case was febrile, and the platelet count remained normal. Both patients voluntarily stopped taking their lithium about 2 weeks before decompensating from bipolar I disorders. Stress was evident in both cases, one from walking on a cold December night after a disagreement, while the other patient in case two was highly agitated and aggressive requiring four-point restraints and intravenous sedation in the ED before admission to NMBHI. Past histories of psychiatric admissions were noted in both cases, and neither subject smoked tobacco – which can increase WBC by 25%-50% with the use of one-two packs per day, respectively.5

These two cases show that clinicians should consider stress in its many permutations to the long list of causes to explain elevated WBC, particularly in the ED. They also illustrate the power of antianxiety medications for some patients with acute mania who present to the ED.

References

1. J Emerg Med. 2012;43(5):866-70.

2. “Wintrobe’s Clinical Hematology,” Philadelphia: Lea & Febiger, 1981, p.1292.

3. “Diagnostic Hematology,” London: Springer, 2009, p. 324.

4. Gen Hosp Psychiatry. 2005;27(6):454-56.

5. Euro Heart J. 2003 Jul;24(14)1365-72.

Dr. Taylor is a staff physician affiliated with the New Mexico Behavioral Health Institute, New Mexico Department of Health, Santa Fe. He reports no financial disclosures or conflicts of interest. The author wishes to thank Dr. Dan Collins from the NMBHI for recommending that he research and write about this topic. In addition, document access was greatly aided by Lisa Apodaca and Mary Bunker, CNP, from the NMBHI, and Karen Ebler and Dr. Irwin Hoffman from Christus St. Vincent Hospital in Santa Fe. Finally, the following colleagues helped by proofreading the manuscript: Dr. Wendy Dimmette, Dr. Richard Nail, and Dr. Matt Streicherz. Eva Romero and Dr. Troy Jones provided useful historical documentation.

References

References

Publications
Publications
Topics
Article Type
Display Headline
CASE REPORTS: Transient neutrophilia in acute mania
Display Headline
CASE REPORTS: Transient neutrophilia in acute mania
Sections
Article Source

PURLs Copyright

Inside the Article

Shiftless

Article Type
Changed
Fri, 01/18/2019 - 15:51
Display Headline
Shiftless

I drive a 10-year-old pickup truck. The air conditioner no longer works – not a real problem here in Maine. It has hand-operated roll down windows ... a real plus should I back too far down the boat ramp and find myself in the cold waters of the Atlantic. If I ever decide to lock it, I will need to use a real key. But the pile of mismatched work gloves and rusty garden tools stashed behind the front seat hasn’t seemed to attract any burglars. Its dented body sits on a new frame, thanks to a generous recall from the manufacturer.

It’s a four-wheel drive, handy in the winter. But what I really like about it is that my old truck has a standard manual transmission. I still have that boyish enthusiasm for shifting gears. I can imagine myself driving a low-slung sports car or operating some gargantuan piece of heavy machinery.

Dr. William G. Wilkoff

Driving a stick shift vehicle demands a level of engagement and concentration several levels above that of simply aiming a car equipped with an automatic transmission. While I am sure some have tried, shifting gears is a serious deterrent to texting at the wheel.

The fact that our three children learned to drive on a standard shift station wagon is a tribute to their parents’ ability to tolerate repeated whiplash injuries. But it also may be one of the reasons that they survived those deadly middle teenage years. Nichole Morris, a researcher at the Human FIRST Laboratory of the University of Minnesota has said, “If you are going to have an early, untimely death, the most dangerous 2 years of your life are between 16 and 17, and the reason for that is driving” (“Teenage Drivers? Be Very Afraid,” by Bruce Feiler, New York Times, March 19, 2016). Six teenagers a day die from motor vehicle accident–related injuries, according to the Centers for Disease Control and Prevention. There are more deaths from motor vehicle accidents in this age group than from suicides, cancer, and other accidents.

©Thinkstock.com

An unfortunate combination of perceived invincibility and inexperience in an environment richly decorated with distractions makes those first years behind the wheel so dangerous. Charlie Klauer, a researcher at Virginia Tech’s Transportation Institute, believes that one in four teenagers will be involved in a motor vehicle crash in his or her first 6 months of driving. My personal experience supports her observation. Luckily, my daughter’s first accident was a low speed rear-ender into a giant pickup truck that sustained no obvious damage.

Given these frightening statistics, it is surprising that any parents would ever allow their teenage children to start on the path toward a driver’s license. As physicians committed to the health and safety of children, why haven’t pediatricians done more to prevent this tragic loss of life? The honest answer is simply that the motor vehicle is too tightly woven into our culture. We have tried, but we could probably do more.

Technological advances such as self-braking cars that are spinning off from the development of autonomous vehicles may save a few teenage drivers. But, watching your 17-year-old child take the wheel for the first time will continue to be an anxiety-provoking experience for the foreseeable future. We can help by reminding parents that the driving is a privilege that can easily be revoked. We must continue to urge parents to create and enforce rules about the use of cell phones behind the wheel. Many states have enacted laws that restrict teenage drivers from driving with other teens in the car, a well-known and often fatal distraction. But parents must be reminded that they are the first line of enforcement.

Enduring those neck-snapping sessions that are unavoidable when your child is learning to drive a standard shift vehicle was a sacrifice my wife and I made gladly. Manual transmissions aren’t coming back. But there are still plenty of sacrifices for today’s parents to make if they want their children to survive those deadly midteen years.

Dr. Wilkoff practiced primary care pediatrics in Brunswick, Maine, for nearly 40 years. He has authored several books on behavioral pediatrics including “How to Say No to Your Toddler.”

References

Author and Disclosure Information

Publications
Topics
Legacy Keywords
teens, driving, smartphones, texting
Sections
Author and Disclosure Information

Author and Disclosure Information

I drive a 10-year-old pickup truck. The air conditioner no longer works – not a real problem here in Maine. It has hand-operated roll down windows ... a real plus should I back too far down the boat ramp and find myself in the cold waters of the Atlantic. If I ever decide to lock it, I will need to use a real key. But the pile of mismatched work gloves and rusty garden tools stashed behind the front seat hasn’t seemed to attract any burglars. Its dented body sits on a new frame, thanks to a generous recall from the manufacturer.

It’s a four-wheel drive, handy in the winter. But what I really like about it is that my old truck has a standard manual transmission. I still have that boyish enthusiasm for shifting gears. I can imagine myself driving a low-slung sports car or operating some gargantuan piece of heavy machinery.

Dr. William G. Wilkoff

Driving a stick shift vehicle demands a level of engagement and concentration several levels above that of simply aiming a car equipped with an automatic transmission. While I am sure some have tried, shifting gears is a serious deterrent to texting at the wheel.

The fact that our three children learned to drive on a standard shift station wagon is a tribute to their parents’ ability to tolerate repeated whiplash injuries. But it also may be one of the reasons that they survived those deadly middle teenage years. Nichole Morris, a researcher at the Human FIRST Laboratory of the University of Minnesota has said, “If you are going to have an early, untimely death, the most dangerous 2 years of your life are between 16 and 17, and the reason for that is driving” (“Teenage Drivers? Be Very Afraid,” by Bruce Feiler, New York Times, March 19, 2016). Six teenagers a day die from motor vehicle accident–related injuries, according to the Centers for Disease Control and Prevention. There are more deaths from motor vehicle accidents in this age group than from suicides, cancer, and other accidents.

©Thinkstock.com

An unfortunate combination of perceived invincibility and inexperience in an environment richly decorated with distractions makes those first years behind the wheel so dangerous. Charlie Klauer, a researcher at Virginia Tech’s Transportation Institute, believes that one in four teenagers will be involved in a motor vehicle crash in his or her first 6 months of driving. My personal experience supports her observation. Luckily, my daughter’s first accident was a low speed rear-ender into a giant pickup truck that sustained no obvious damage.

Given these frightening statistics, it is surprising that any parents would ever allow their teenage children to start on the path toward a driver’s license. As physicians committed to the health and safety of children, why haven’t pediatricians done more to prevent this tragic loss of life? The honest answer is simply that the motor vehicle is too tightly woven into our culture. We have tried, but we could probably do more.

Technological advances such as self-braking cars that are spinning off from the development of autonomous vehicles may save a few teenage drivers. But, watching your 17-year-old child take the wheel for the first time will continue to be an anxiety-provoking experience for the foreseeable future. We can help by reminding parents that the driving is a privilege that can easily be revoked. We must continue to urge parents to create and enforce rules about the use of cell phones behind the wheel. Many states have enacted laws that restrict teenage drivers from driving with other teens in the car, a well-known and often fatal distraction. But parents must be reminded that they are the first line of enforcement.

Enduring those neck-snapping sessions that are unavoidable when your child is learning to drive a standard shift vehicle was a sacrifice my wife and I made gladly. Manual transmissions aren’t coming back. But there are still plenty of sacrifices for today’s parents to make if they want their children to survive those deadly midteen years.

Dr. Wilkoff practiced primary care pediatrics in Brunswick, Maine, for nearly 40 years. He has authored several books on behavioral pediatrics including “How to Say No to Your Toddler.”

I drive a 10-year-old pickup truck. The air conditioner no longer works – not a real problem here in Maine. It has hand-operated roll down windows ... a real plus should I back too far down the boat ramp and find myself in the cold waters of the Atlantic. If I ever decide to lock it, I will need to use a real key. But the pile of mismatched work gloves and rusty garden tools stashed behind the front seat hasn’t seemed to attract any burglars. Its dented body sits on a new frame, thanks to a generous recall from the manufacturer.

It’s a four-wheel drive, handy in the winter. But what I really like about it is that my old truck has a standard manual transmission. I still have that boyish enthusiasm for shifting gears. I can imagine myself driving a low-slung sports car or operating some gargantuan piece of heavy machinery.

Dr. William G. Wilkoff

Driving a stick shift vehicle demands a level of engagement and concentration several levels above that of simply aiming a car equipped with an automatic transmission. While I am sure some have tried, shifting gears is a serious deterrent to texting at the wheel.

The fact that our three children learned to drive on a standard shift station wagon is a tribute to their parents’ ability to tolerate repeated whiplash injuries. But it also may be one of the reasons that they survived those deadly middle teenage years. Nichole Morris, a researcher at the Human FIRST Laboratory of the University of Minnesota has said, “If you are going to have an early, untimely death, the most dangerous 2 years of your life are between 16 and 17, and the reason for that is driving” (“Teenage Drivers? Be Very Afraid,” by Bruce Feiler, New York Times, March 19, 2016). Six teenagers a day die from motor vehicle accident–related injuries, according to the Centers for Disease Control and Prevention. There are more deaths from motor vehicle accidents in this age group than from suicides, cancer, and other accidents.

©Thinkstock.com

An unfortunate combination of perceived invincibility and inexperience in an environment richly decorated with distractions makes those first years behind the wheel so dangerous. Charlie Klauer, a researcher at Virginia Tech’s Transportation Institute, believes that one in four teenagers will be involved in a motor vehicle crash in his or her first 6 months of driving. My personal experience supports her observation. Luckily, my daughter’s first accident was a low speed rear-ender into a giant pickup truck that sustained no obvious damage.

Given these frightening statistics, it is surprising that any parents would ever allow their teenage children to start on the path toward a driver’s license. As physicians committed to the health and safety of children, why haven’t pediatricians done more to prevent this tragic loss of life? The honest answer is simply that the motor vehicle is too tightly woven into our culture. We have tried, but we could probably do more.

Technological advances such as self-braking cars that are spinning off from the development of autonomous vehicles may save a few teenage drivers. But, watching your 17-year-old child take the wheel for the first time will continue to be an anxiety-provoking experience for the foreseeable future. We can help by reminding parents that the driving is a privilege that can easily be revoked. We must continue to urge parents to create and enforce rules about the use of cell phones behind the wheel. Many states have enacted laws that restrict teenage drivers from driving with other teens in the car, a well-known and often fatal distraction. But parents must be reminded that they are the first line of enforcement.

Enduring those neck-snapping sessions that are unavoidable when your child is learning to drive a standard shift vehicle was a sacrifice my wife and I made gladly. Manual transmissions aren’t coming back. But there are still plenty of sacrifices for today’s parents to make if they want their children to survive those deadly midteen years.

Dr. Wilkoff practiced primary care pediatrics in Brunswick, Maine, for nearly 40 years. He has authored several books on behavioral pediatrics including “How to Say No to Your Toddler.”

References

References

Publications
Publications
Topics
Article Type
Display Headline
Shiftless
Display Headline
Shiftless
Legacy Keywords
teens, driving, smartphones, texting
Legacy Keywords
teens, driving, smartphones, texting
Sections
Article Source

PURLs Copyright

Inside the Article

Lessons From History: The Ethical Foundation of VA Health Care

Article Type
Changed
Tue, 07/11/2017 - 12:07
Display Headline
Lessons From History: The Ethical Foundation of VA Health Care

We are all familiar with the constellation of ethical lapses ignominiously referred to as “the VA scandal of 2014.” Amid the negative publicity, Congressional hearings, and legislative and agency efforts, little attention has been given to the historic foundations of the VA that make it a unique and vital part of American health care. Yet, unless the new positive initiatives, such as the Veterans Choice Program, are built on core VA ethical principles and values, the new model of health care delivery may undermine VA’s distinctive mission.1

That mission began in the last months of the bloodiest conflict in American history—the Civil War. In his second inaugural address, President Abraham Lincoln presented the fight to end slavery in the U.S. in religious and moral terms. The VA was conceived conceptually and institutionally in this speech as a part of the strategy to reunify the divided nation and an effort to heal an anguished people. In the words that grace the walls of many VA hospitals, President Lincoln articulated our commitment to those who fought and died in a terrible war for an awesome cause:

With malice toward none, with charity for all, with firmness in the right as God gives us to see the right, let us strive on to finish the work we are in, to bind up the nation’s wounds, to care for him who shall have borne the battle and for his widow and his orphan, to do all which may achieve and cherish a just and lasting peace among ourselves and with all nations.2

Although couched in poetic terms, this speech established the VA in the technical language of organizational systems as an “entitlement program.” Currently, there are 3 major federal entitlement health care programs: Medicare, Medicaid, and the VHA.3 The U.S. has other social entitlement programs, such as Social Security, unemployment insurance, food stamps, and federal retirement programs. In political and economic theory, “entitlement” is defined in the ethically salient language of rights. This is the type of “program that offers individuals who meet eligibility requirements personal financial benefits (or sometimes special government-provided goods or services) to which an indefinite (but usually rather large) number of potential beneficiaries have a legal right.”4

However, there is a morally and politically important difference between the majority of these other entitlement programs and the VA. Citizens pay taxes during their working life into tax-based programs like Social Security and Medicare and thus, they have a “title to” benefits. They have, in simple economics, earned these benefits and have a right to them. Veterans also have paid into the system, but the payment is not monetary; it is in blood, sweat, tears, and in some instances, life itself. In a civilized society, the contributions made by service members bear the highest value, ones that cannot be counted in money. This obligation of reciprocity to provide health care to those who served is what defines the fundamental ethical nature of VA as an organization and what makes it different from all other systems, however noble their missions.

The controversy about the Affordable Care Act is the latest round in a long American struggle over the nature of health care. Is it a basic human right as most European countries have decided? Is it a commodity like other goods in our capitalist society, and so the object of the laws of supply and demand? Is it a privilege earned through employment, insurance, or other qualifications in accordance with our bootstrap ideology? Is it a service given to the poor and disabled as an expression of government’s parens patriae duty to care for all its citizens?5 Unresolved as the question remains for many Americans, for veterans the issue was settled in 1865 when President Lincoln declared that those members of the armed forces who suffered illness or injury in battle or died in war have a legally guaranteed and perhaps a religiously sanctioned right to health care.

Legislation would later specify and expand veterans’ benefits to include more extensive and intensive health care to veterans whose disabilities are connected to their service as well as those with few financial resources. This prioritization underscores an important point: What entitles patients to benefits are the mental and physical injuries that veterans have sustained as a result of military service along with the social and economic costs often associated with their service. It also introduces an additional dimension of fairness to the entitlement criteria. These eligibility rules cohere with the original purpose of the VA as it seeks to “care for him who shall have borne the battle” and those for whom the war had taken the greatest toll (clinically or socioeconomically).

 

 

There are health care experts, politicians, even ethicists, who have called for either complete overhauling or dismantling of the old and swaying VHA edifice and furloughing or firing its demoralized and overworked staff. But before the wrecking crews come in and the ranks of committed and competent VA employees are sent packing, the naysayers should stop and realize that no matter what may be gained in that process, we will have profoundly changed the founding purpose and mission of the VA. The VA has one reason for existence—to care for veterans. Long before patient-centered care and medical homes were bywords in health care parlance, they were the words of ethical justification for the VHA as a health care agency. No moral agent, be it a person or an institution, can serve 2 masters. The VA is the only major health care system in the U.S. that does not have dual and often conflicting interests, whether in mission-readiness, profit, religious faith, or local and state politics.

There may be disagreements about the nature and scope of VHA’s problems and their solutions, but we should all recognize that a deeper ethical problem exists if the federal government and VHA fail to fulfill the obligation of reciprocity so eloquently described by President Lincoln. Economics can inform and empower but never fully resolve what is at the heart an ethical issue. Accountability and integrity are fundamental ethical values that are easily eroded by a singular and punitive focus on rules and rule-breaking that have guided too much of VA’s action and inaction, as well as the reaction of Congress. The military motto is to “leave no solider behind.” President Lincoln created the VA to honor this promise to veterans when they returned to civilian life. We must not allow engagement in partisan clashes to prevent us from fulfilling our moral commitment to those who actually fought and supported the nation’s battles. 

Aknowledgements
The editor thanks Virginia Ashby Sharpe, PhD, for her insightful comments on an earlier draft of this editorial.

References

 

1. Shulkin DJ. Beyond the VA crises-becoming a high-performance network. N Engl J Med. 2016;374(11):1003-1005.

2. U.S. Department of Veterans Affairs. The origin of the VA motto: Lincoln’s second inaugural address. U.S. Department of Veterans Affairs Website. http://www.va.gov/opa/publications/celebrate/vamotto.pdf. Accessed March 21, 2016.

3. Shi L, Singh DA. Delivering Health Care in America: A Systems Approach. 3rd ed. Sudbury, MA: Jones and Bartlett; 2004.

4. Johnson PM. A glossary of political economy terms: entitlement program. Auburn University Website. https://www.auburn.edu/~johnspm/gloss/entitlement_program. Accessed March 21, 2016.

5. Should all Americans have the right (be entitled) to health care? ProCon.org Website. http://healthcare.procon.org/view.answers.php?questionID=001602. Accessed March 21, 2016.

6. Core values and characteristics of the department. Fed Regist. 2012;77(135):41273-41276. 38 CFR Part 0.

Article PDF
Author and Disclosure Information

Author disclosures
The author reports no actual or potential conflicts of interest with regard to this article.

Disclaimer
The opinions expressed herein are those of the author and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the U.S. Government, or any of its agencies.

Issue
Federal Practitioner - 33(4)
Publications
Page Number
6-7
Legacy Keywords
ethics, VA health care
Sections
Author and Disclosure Information

Author disclosures
The author reports no actual or potential conflicts of interest with regard to this article.

Disclaimer
The opinions expressed herein are those of the author and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the U.S. Government, or any of its agencies.

Author and Disclosure Information

Author disclosures
The author reports no actual or potential conflicts of interest with regard to this article.

Disclaimer
The opinions expressed herein are those of the author and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the U.S. Government, or any of its agencies.

Article PDF
Article PDF

We are all familiar with the constellation of ethical lapses ignominiously referred to as “the VA scandal of 2014.” Amid the negative publicity, Congressional hearings, and legislative and agency efforts, little attention has been given to the historic foundations of the VA that make it a unique and vital part of American health care. Yet, unless the new positive initiatives, such as the Veterans Choice Program, are built on core VA ethical principles and values, the new model of health care delivery may undermine VA’s distinctive mission.1

That mission began in the last months of the bloodiest conflict in American history—the Civil War. In his second inaugural address, President Abraham Lincoln presented the fight to end slavery in the U.S. in religious and moral terms. The VA was conceived conceptually and institutionally in this speech as a part of the strategy to reunify the divided nation and an effort to heal an anguished people. In the words that grace the walls of many VA hospitals, President Lincoln articulated our commitment to those who fought and died in a terrible war for an awesome cause:

With malice toward none, with charity for all, with firmness in the right as God gives us to see the right, let us strive on to finish the work we are in, to bind up the nation’s wounds, to care for him who shall have borne the battle and for his widow and his orphan, to do all which may achieve and cherish a just and lasting peace among ourselves and with all nations.2

Although couched in poetic terms, this speech established the VA in the technical language of organizational systems as an “entitlement program.” Currently, there are 3 major federal entitlement health care programs: Medicare, Medicaid, and the VHA.3 The U.S. has other social entitlement programs, such as Social Security, unemployment insurance, food stamps, and federal retirement programs. In political and economic theory, “entitlement” is defined in the ethically salient language of rights. This is the type of “program that offers individuals who meet eligibility requirements personal financial benefits (or sometimes special government-provided goods or services) to which an indefinite (but usually rather large) number of potential beneficiaries have a legal right.”4

However, there is a morally and politically important difference between the majority of these other entitlement programs and the VA. Citizens pay taxes during their working life into tax-based programs like Social Security and Medicare and thus, they have a “title to” benefits. They have, in simple economics, earned these benefits and have a right to them. Veterans also have paid into the system, but the payment is not monetary; it is in blood, sweat, tears, and in some instances, life itself. In a civilized society, the contributions made by service members bear the highest value, ones that cannot be counted in money. This obligation of reciprocity to provide health care to those who served is what defines the fundamental ethical nature of VA as an organization and what makes it different from all other systems, however noble their missions.

The controversy about the Affordable Care Act is the latest round in a long American struggle over the nature of health care. Is it a basic human right as most European countries have decided? Is it a commodity like other goods in our capitalist society, and so the object of the laws of supply and demand? Is it a privilege earned through employment, insurance, or other qualifications in accordance with our bootstrap ideology? Is it a service given to the poor and disabled as an expression of government’s parens patriae duty to care for all its citizens?5 Unresolved as the question remains for many Americans, for veterans the issue was settled in 1865 when President Lincoln declared that those members of the armed forces who suffered illness or injury in battle or died in war have a legally guaranteed and perhaps a religiously sanctioned right to health care.

Legislation would later specify and expand veterans’ benefits to include more extensive and intensive health care to veterans whose disabilities are connected to their service as well as those with few financial resources. This prioritization underscores an important point: What entitles patients to benefits are the mental and physical injuries that veterans have sustained as a result of military service along with the social and economic costs often associated with their service. It also introduces an additional dimension of fairness to the entitlement criteria. These eligibility rules cohere with the original purpose of the VA as it seeks to “care for him who shall have borne the battle” and those for whom the war had taken the greatest toll (clinically or socioeconomically).

 

 

There are health care experts, politicians, even ethicists, who have called for either complete overhauling or dismantling of the old and swaying VHA edifice and furloughing or firing its demoralized and overworked staff. But before the wrecking crews come in and the ranks of committed and competent VA employees are sent packing, the naysayers should stop and realize that no matter what may be gained in that process, we will have profoundly changed the founding purpose and mission of the VA. The VA has one reason for existence—to care for veterans. Long before patient-centered care and medical homes were bywords in health care parlance, they were the words of ethical justification for the VHA as a health care agency. No moral agent, be it a person or an institution, can serve 2 masters. The VA is the only major health care system in the U.S. that does not have dual and often conflicting interests, whether in mission-readiness, profit, religious faith, or local and state politics.

There may be disagreements about the nature and scope of VHA’s problems and their solutions, but we should all recognize that a deeper ethical problem exists if the federal government and VHA fail to fulfill the obligation of reciprocity so eloquently described by President Lincoln. Economics can inform and empower but never fully resolve what is at the heart an ethical issue. Accountability and integrity are fundamental ethical values that are easily eroded by a singular and punitive focus on rules and rule-breaking that have guided too much of VA’s action and inaction, as well as the reaction of Congress. The military motto is to “leave no solider behind.” President Lincoln created the VA to honor this promise to veterans when they returned to civilian life. We must not allow engagement in partisan clashes to prevent us from fulfilling our moral commitment to those who actually fought and supported the nation’s battles. 

Aknowledgements
The editor thanks Virginia Ashby Sharpe, PhD, for her insightful comments on an earlier draft of this editorial.

We are all familiar with the constellation of ethical lapses ignominiously referred to as “the VA scandal of 2014.” Amid the negative publicity, Congressional hearings, and legislative and agency efforts, little attention has been given to the historic foundations of the VA that make it a unique and vital part of American health care. Yet, unless the new positive initiatives, such as the Veterans Choice Program, are built on core VA ethical principles and values, the new model of health care delivery may undermine VA’s distinctive mission.1

That mission began in the last months of the bloodiest conflict in American history—the Civil War. In his second inaugural address, President Abraham Lincoln presented the fight to end slavery in the U.S. in religious and moral terms. The VA was conceived conceptually and institutionally in this speech as a part of the strategy to reunify the divided nation and an effort to heal an anguished people. In the words that grace the walls of many VA hospitals, President Lincoln articulated our commitment to those who fought and died in a terrible war for an awesome cause:

With malice toward none, with charity for all, with firmness in the right as God gives us to see the right, let us strive on to finish the work we are in, to bind up the nation’s wounds, to care for him who shall have borne the battle and for his widow and his orphan, to do all which may achieve and cherish a just and lasting peace among ourselves and with all nations.2

Although couched in poetic terms, this speech established the VA in the technical language of organizational systems as an “entitlement program.” Currently, there are 3 major federal entitlement health care programs: Medicare, Medicaid, and the VHA.3 The U.S. has other social entitlement programs, such as Social Security, unemployment insurance, food stamps, and federal retirement programs. In political and economic theory, “entitlement” is defined in the ethically salient language of rights. This is the type of “program that offers individuals who meet eligibility requirements personal financial benefits (or sometimes special government-provided goods or services) to which an indefinite (but usually rather large) number of potential beneficiaries have a legal right.”4

However, there is a morally and politically important difference between the majority of these other entitlement programs and the VA. Citizens pay taxes during their working life into tax-based programs like Social Security and Medicare and thus, they have a “title to” benefits. They have, in simple economics, earned these benefits and have a right to them. Veterans also have paid into the system, but the payment is not monetary; it is in blood, sweat, tears, and in some instances, life itself. In a civilized society, the contributions made by service members bear the highest value, ones that cannot be counted in money. This obligation of reciprocity to provide health care to those who served is what defines the fundamental ethical nature of VA as an organization and what makes it different from all other systems, however noble their missions.

The controversy about the Affordable Care Act is the latest round in a long American struggle over the nature of health care. Is it a basic human right as most European countries have decided? Is it a commodity like other goods in our capitalist society, and so the object of the laws of supply and demand? Is it a privilege earned through employment, insurance, or other qualifications in accordance with our bootstrap ideology? Is it a service given to the poor and disabled as an expression of government’s parens patriae duty to care for all its citizens?5 Unresolved as the question remains for many Americans, for veterans the issue was settled in 1865 when President Lincoln declared that those members of the armed forces who suffered illness or injury in battle or died in war have a legally guaranteed and perhaps a religiously sanctioned right to health care.

Legislation would later specify and expand veterans’ benefits to include more extensive and intensive health care to veterans whose disabilities are connected to their service as well as those with few financial resources. This prioritization underscores an important point: What entitles patients to benefits are the mental and physical injuries that veterans have sustained as a result of military service along with the social and economic costs often associated with their service. It also introduces an additional dimension of fairness to the entitlement criteria. These eligibility rules cohere with the original purpose of the VA as it seeks to “care for him who shall have borne the battle” and those for whom the war had taken the greatest toll (clinically or socioeconomically).

 

 

There are health care experts, politicians, even ethicists, who have called for either complete overhauling or dismantling of the old and swaying VHA edifice and furloughing or firing its demoralized and overworked staff. But before the wrecking crews come in and the ranks of committed and competent VA employees are sent packing, the naysayers should stop and realize that no matter what may be gained in that process, we will have profoundly changed the founding purpose and mission of the VA. The VA has one reason for existence—to care for veterans. Long before patient-centered care and medical homes were bywords in health care parlance, they were the words of ethical justification for the VHA as a health care agency. No moral agent, be it a person or an institution, can serve 2 masters. The VA is the only major health care system in the U.S. that does not have dual and often conflicting interests, whether in mission-readiness, profit, religious faith, or local and state politics.

There may be disagreements about the nature and scope of VHA’s problems and their solutions, but we should all recognize that a deeper ethical problem exists if the federal government and VHA fail to fulfill the obligation of reciprocity so eloquently described by President Lincoln. Economics can inform and empower but never fully resolve what is at the heart an ethical issue. Accountability and integrity are fundamental ethical values that are easily eroded by a singular and punitive focus on rules and rule-breaking that have guided too much of VA’s action and inaction, as well as the reaction of Congress. The military motto is to “leave no solider behind.” President Lincoln created the VA to honor this promise to veterans when they returned to civilian life. We must not allow engagement in partisan clashes to prevent us from fulfilling our moral commitment to those who actually fought and supported the nation’s battles. 

Aknowledgements
The editor thanks Virginia Ashby Sharpe, PhD, for her insightful comments on an earlier draft of this editorial.

References

 

1. Shulkin DJ. Beyond the VA crises-becoming a high-performance network. N Engl J Med. 2016;374(11):1003-1005.

2. U.S. Department of Veterans Affairs. The origin of the VA motto: Lincoln’s second inaugural address. U.S. Department of Veterans Affairs Website. http://www.va.gov/opa/publications/celebrate/vamotto.pdf. Accessed March 21, 2016.

3. Shi L, Singh DA. Delivering Health Care in America: A Systems Approach. 3rd ed. Sudbury, MA: Jones and Bartlett; 2004.

4. Johnson PM. A glossary of political economy terms: entitlement program. Auburn University Website. https://www.auburn.edu/~johnspm/gloss/entitlement_program. Accessed March 21, 2016.

5. Should all Americans have the right (be entitled) to health care? ProCon.org Website. http://healthcare.procon.org/view.answers.php?questionID=001602. Accessed March 21, 2016.

6. Core values and characteristics of the department. Fed Regist. 2012;77(135):41273-41276. 38 CFR Part 0.

References

 

1. Shulkin DJ. Beyond the VA crises-becoming a high-performance network. N Engl J Med. 2016;374(11):1003-1005.

2. U.S. Department of Veterans Affairs. The origin of the VA motto: Lincoln’s second inaugural address. U.S. Department of Veterans Affairs Website. http://www.va.gov/opa/publications/celebrate/vamotto.pdf. Accessed March 21, 2016.

3. Shi L, Singh DA. Delivering Health Care in America: A Systems Approach. 3rd ed. Sudbury, MA: Jones and Bartlett; 2004.

4. Johnson PM. A glossary of political economy terms: entitlement program. Auburn University Website. https://www.auburn.edu/~johnspm/gloss/entitlement_program. Accessed March 21, 2016.

5. Should all Americans have the right (be entitled) to health care? ProCon.org Website. http://healthcare.procon.org/view.answers.php?questionID=001602. Accessed March 21, 2016.

6. Core values and characteristics of the department. Fed Regist. 2012;77(135):41273-41276. 38 CFR Part 0.

Issue
Federal Practitioner - 33(4)
Issue
Federal Practitioner - 33(4)
Page Number
6-7
Page Number
6-7
Publications
Publications
Article Type
Display Headline
Lessons From History: The Ethical Foundation of VA Health Care
Display Headline
Lessons From History: The Ethical Foundation of VA Health Care
Legacy Keywords
ethics, VA health care
Legacy Keywords
ethics, VA health care
Sections
Disallow All Ads
Alternative CME
Article PDF Media

Advances in IV nutrition for very low birth weight neonates

Article Type
Changed
Thu, 12/06/2018 - 17:53
Display Headline
Advances in IV nutrition for very low birth weight neonates

Premature neonates are at high risk for growth failure and a host of morbidities including sepsis, chronic lung disease, necrotizing enterocolitis, retinopathy of prematurity, cholestasis, and neurodevelopmental impairment. Nutrition plays an important role in modulating disease. Virtually all extremely low birth weight neonates (birth weight less than 1 kg) receive parenteral nutrition and intravenous lipids in order to promote optimal nutrition and growth. Intravenous lipids provide nonprotein calories and the essential fatty acids linoleic acid (an omega-6 fatty acid) and alpha-linoleic acid (an omega-3 fatty acid). High omega-6:omega-3 fatty acid ratios promote inflammation and have been associated with various adult-onset diseases, including cardiovascular disease, diabetes, and cancer.

Currently, the only Food and Drug Administration–approved lipid emulsion is entirely soybean based (Intralipid). This lipid emulsion contains a high omega-6:omega-3 fatty acid ratio, high concentrations of linoleic and alpha-linoleic acid, and lacks arachidonic acid (ARA, an omega-6 fatty acid) and docosahexaenoic acid (DHA, an omega-3 fatty acid). Moreover, soybean oil contains a small amount of vitamin E, an antioxidant which helps prevent lipid peroxidation and oxidative stress. A non–FDA approved lipid emulsion (SMOFlipid) is currently being prescribed to children, including preterm neonates, in Europe. SMOFlipid contains a “mix” of various oils (30% soy, 15% fish, 30% coconut, and 25% olive oil) and a higher concentration of Vitamin E (48 mg/dL vs. 38 mg/dL). In comparison with soybean oil, SMOFlipid’s fatty acid content more closely resembles breast milk with a more physiologically appropriate omega-6:omega-3 fatty acid ratio. As a result, SMOFlipid theoretically may have the capability to modulate disease by decreasing systemic inflammation and tissue injury.

Dr. Kara L. Calkins

In small retrospective and randomized controlled trials, preterm neonates who received SMOFlipid have increased ARA, DHA, and vitamin E concentrations and decreased markers of oxidative stress, compared with neonates who received standard soybean oil1-3. Improving the DHA and ARA status in preterm neonates has several theoretical advantages. DHA and ARA are preferentially transferred to the fetus during the third trimester of pregnancy, and found in significant quantities in the brain, retina, and breast milk. Under normal physiological conditions, linoleic and alpha-linoleic acid, which cannot be synthesized de novo, are metabolized to ARA and DHA. Despite being provided with linoleic and alpha-linoleic acid in intravenous soybean oil, preterm neonates develop ARA and DHA deficiencies. Preterm neonates lack the necessary enzymatic machinery (due to immature livers) to convert these essential fatty acids into their downstream products. ARA and DHA deficiencies have been linked to the development of bronchopulmonary dysplasia and retinopathy of prematurity. Infant formulas now contain DHA and ARA, and have been associated with improved visual and cognitive outcomes. Because very low birth weight neonates are at high risk for growth failure and neurological impairment along with other comorbidities, many people believe that intravenous lipids should contain pre-formed ARA and DHA. However, it remains to be determined if an improved fatty acid profile in this population translates into better long-term outcomes.

Soybean-based lipids also have been heavily criticized for their high concentrations of hepatotoxic phytosterols, which have been linked to parenteral nutrition associated liver disease (PNALD). Neonates are at high risk for PNALD because of immature livers and the need for prolonged courses of parenteral nutrition. Twenty percent to 60% of premature neonates and children with gastrointestinal disorders will develop PNALD. In neonates with short bowel syndrome, the highest-risk subgroup, 70% will develop PNALD and 20% will progress to liver failure. Once end-stage liver disease develops, an isolated liver or combined small bowel-liver transplant may be the only life-saving measure. Due to the high mortality of end-stage PNALD, small size of transplant candidates, and shortage of organ donors, 50% of children awaiting a transplant will not survive. Five-year post-transplant survival is 60%-70% and fraught with a complex lifestyle. Transplants also carry a high price tag with an estimated cost of $1.5-$1.9 million in the first year.

In comparison with soybean oil, SMOFlipid has a reduced concentration of phytosterols (48 mg/L vs. 343 mg/L). Phytosterols are only found in plant food sources and approximately 5%-10% of phytosterols are absorbed in the intestine. As a result, in a healthy child, they are present at minimal concentrations in the bloodstream. Children receiving parenteral nutrition and with PNALD have higher concentrations of phytosterols, compared with controls. High concentrations of phytosterol reduce the expression of hepatic bilirubin and bile acid transporters. As a result, as phytosterol concentrations rise, bile acids and bilirubin are retained in the liver, causing cholestasis. Like phytosterols, cytokines cause a decrease in biliary flow. Hence, soybean oil’s high concentration of phytosterols and omega-6 fatty acids, which causes a shift toward a proinflammatory state, act synergistically to promote liver injury. SMOFlipid’s reduced phytosterol content potentially may have important implications with regards to the development and progression of PNALD. In randomized controlled trials, neonates who received SMOFlipid had decreased phytosterol concentrations and improved liver function tests, compared with neonates who received soybean oil. Larger studies are needed to determine if SMOFlipid reduces the incidence or severity of PNALD.

 

 

©herjua/Thinkstock.com

In children with advanced PNALD, low dose fish oil monotherapy (Omegaven) has been shown to biochemically reverse cholestasis4,5. Like SMOFlipid, Omegaven is not FDA approved and its use is restricted throughout the United States. Omegaven is dosed at 1 g/kg per day, lacks phytosterols, and contains high concentrations of the anti-inflammatory omega-3 fatty acids DHA and eicosapentaenoic acid, and vitamin E. Based on the assumption that reducing the liver’s exposure to phytosterols and omega-6 fatty acids treats PNALD, it has now become common clinical practice in many neonatal intensive care units to prescribe low dose soybean oil for PNALD prevention. While observational data suggests low dose soybean oil (1 g/kg per day or less) reduces the incidence of PNALD, randomized controlled trials have not demonstrated a change in cholestasis. Lipid sparing (fish or soy) is not without risks, particularly in high-risk populations such as preterm neonates. Inadequate lipid intake during a period of rapid growth and development could cause a fatty acid deficiency and impair growth and neurodevelopment. The central nervous system contains high concentrations of lipids, which are important for cell structure and function and gene transcription. One of the advantages of SMOFlipid is that it can be dosed at 3 g/kg per day, unlike Omegaven, and may be more likely to meet the lipid requirement of neonates.

In summary, the current FDA-approved soy-based lipid product was not designed to meet the nutritional needs of the preterm infant. An ideal lipid emulsion would provide adequate concentrations of polyunsaturated fatty acids, promote growth, be free of phytosterols, and minimize inflammation and other adverse sequelae. SMOFlipid may be more likely to meet the DHA and ARA requirement of the premature neonate. A mixed lipid emulsion dosed at 3 g/kg per day may improve growth and long-term neurodevelopment and reduce the incidence of parenteral nutrition associated liver disease along with other common neonatal diseases. In turn, this may reduce health care related costs. Appropriately powered, well-designed randomized controlled trials with long-term follow-up are needed to evaluate this new lipid emulsion.

References

1. J Pediatr Gastroenterol Nutr. 2010 Oct;51(4):514-21.

2. Nutr Clin Pract. 2012 Dec;27(6):817-24.

3. J Pediatr Gastroenterol Nutr. 2014 Apr;58(4):417-27.

4. JPEN J Parenter Enteral Nutr. 2016 Mar;40(3):374-82.

5. JPEN J Parenter Enteral Nutr. 2014 Aug;38(6):682-92.

Dr. Calkins is an assistant professor of pediatrics in the division of neonatology at the University of California, Los Angeles. She receives research funding from Fresenius Kabi, the German manufacturer of the products described in this article. The terms of this arrangement have been reviewed by UCLA in accordance with its conflict of interest policy. Because there is only one manufacturer for some of the products discussed in this article, for clarity we have chosen to use brand names rather than generic names. Email Dr. Calkins at [email protected].

References

Author and Disclosure Information

Publications
Topics
Legacy Keywords
preemies, iv, lipids, VLBW, babies
Sections
Author and Disclosure Information

Author and Disclosure Information

Premature neonates are at high risk for growth failure and a host of morbidities including sepsis, chronic lung disease, necrotizing enterocolitis, retinopathy of prematurity, cholestasis, and neurodevelopmental impairment. Nutrition plays an important role in modulating disease. Virtually all extremely low birth weight neonates (birth weight less than 1 kg) receive parenteral nutrition and intravenous lipids in order to promote optimal nutrition and growth. Intravenous lipids provide nonprotein calories and the essential fatty acids linoleic acid (an omega-6 fatty acid) and alpha-linoleic acid (an omega-3 fatty acid). High omega-6:omega-3 fatty acid ratios promote inflammation and have been associated with various adult-onset diseases, including cardiovascular disease, diabetes, and cancer.

Currently, the only Food and Drug Administration–approved lipid emulsion is entirely soybean based (Intralipid). This lipid emulsion contains a high omega-6:omega-3 fatty acid ratio, high concentrations of linoleic and alpha-linoleic acid, and lacks arachidonic acid (ARA, an omega-6 fatty acid) and docosahexaenoic acid (DHA, an omega-3 fatty acid). Moreover, soybean oil contains a small amount of vitamin E, an antioxidant which helps prevent lipid peroxidation and oxidative stress. A non–FDA approved lipid emulsion (SMOFlipid) is currently being prescribed to children, including preterm neonates, in Europe. SMOFlipid contains a “mix” of various oils (30% soy, 15% fish, 30% coconut, and 25% olive oil) and a higher concentration of Vitamin E (48 mg/dL vs. 38 mg/dL). In comparison with soybean oil, SMOFlipid’s fatty acid content more closely resembles breast milk with a more physiologically appropriate omega-6:omega-3 fatty acid ratio. As a result, SMOFlipid theoretically may have the capability to modulate disease by decreasing systemic inflammation and tissue injury.

Dr. Kara L. Calkins

In small retrospective and randomized controlled trials, preterm neonates who received SMOFlipid have increased ARA, DHA, and vitamin E concentrations and decreased markers of oxidative stress, compared with neonates who received standard soybean oil1-3. Improving the DHA and ARA status in preterm neonates has several theoretical advantages. DHA and ARA are preferentially transferred to the fetus during the third trimester of pregnancy, and found in significant quantities in the brain, retina, and breast milk. Under normal physiological conditions, linoleic and alpha-linoleic acid, which cannot be synthesized de novo, are metabolized to ARA and DHA. Despite being provided with linoleic and alpha-linoleic acid in intravenous soybean oil, preterm neonates develop ARA and DHA deficiencies. Preterm neonates lack the necessary enzymatic machinery (due to immature livers) to convert these essential fatty acids into their downstream products. ARA and DHA deficiencies have been linked to the development of bronchopulmonary dysplasia and retinopathy of prematurity. Infant formulas now contain DHA and ARA, and have been associated with improved visual and cognitive outcomes. Because very low birth weight neonates are at high risk for growth failure and neurological impairment along with other comorbidities, many people believe that intravenous lipids should contain pre-formed ARA and DHA. However, it remains to be determined if an improved fatty acid profile in this population translates into better long-term outcomes.

Soybean-based lipids also have been heavily criticized for their high concentrations of hepatotoxic phytosterols, which have been linked to parenteral nutrition associated liver disease (PNALD). Neonates are at high risk for PNALD because of immature livers and the need for prolonged courses of parenteral nutrition. Twenty percent to 60% of premature neonates and children with gastrointestinal disorders will develop PNALD. In neonates with short bowel syndrome, the highest-risk subgroup, 70% will develop PNALD and 20% will progress to liver failure. Once end-stage liver disease develops, an isolated liver or combined small bowel-liver transplant may be the only life-saving measure. Due to the high mortality of end-stage PNALD, small size of transplant candidates, and shortage of organ donors, 50% of children awaiting a transplant will not survive. Five-year post-transplant survival is 60%-70% and fraught with a complex lifestyle. Transplants also carry a high price tag with an estimated cost of $1.5-$1.9 million in the first year.

In comparison with soybean oil, SMOFlipid has a reduced concentration of phytosterols (48 mg/L vs. 343 mg/L). Phytosterols are only found in plant food sources and approximately 5%-10% of phytosterols are absorbed in the intestine. As a result, in a healthy child, they are present at minimal concentrations in the bloodstream. Children receiving parenteral nutrition and with PNALD have higher concentrations of phytosterols, compared with controls. High concentrations of phytosterol reduce the expression of hepatic bilirubin and bile acid transporters. As a result, as phytosterol concentrations rise, bile acids and bilirubin are retained in the liver, causing cholestasis. Like phytosterols, cytokines cause a decrease in biliary flow. Hence, soybean oil’s high concentration of phytosterols and omega-6 fatty acids, which causes a shift toward a proinflammatory state, act synergistically to promote liver injury. SMOFlipid’s reduced phytosterol content potentially may have important implications with regards to the development and progression of PNALD. In randomized controlled trials, neonates who received SMOFlipid had decreased phytosterol concentrations and improved liver function tests, compared with neonates who received soybean oil. Larger studies are needed to determine if SMOFlipid reduces the incidence or severity of PNALD.

 

 

©herjua/Thinkstock.com

In children with advanced PNALD, low dose fish oil monotherapy (Omegaven) has been shown to biochemically reverse cholestasis4,5. Like SMOFlipid, Omegaven is not FDA approved and its use is restricted throughout the United States. Omegaven is dosed at 1 g/kg per day, lacks phytosterols, and contains high concentrations of the anti-inflammatory omega-3 fatty acids DHA and eicosapentaenoic acid, and vitamin E. Based on the assumption that reducing the liver’s exposure to phytosterols and omega-6 fatty acids treats PNALD, it has now become common clinical practice in many neonatal intensive care units to prescribe low dose soybean oil for PNALD prevention. While observational data suggests low dose soybean oil (1 g/kg per day or less) reduces the incidence of PNALD, randomized controlled trials have not demonstrated a change in cholestasis. Lipid sparing (fish or soy) is not without risks, particularly in high-risk populations such as preterm neonates. Inadequate lipid intake during a period of rapid growth and development could cause a fatty acid deficiency and impair growth and neurodevelopment. The central nervous system contains high concentrations of lipids, which are important for cell structure and function and gene transcription. One of the advantages of SMOFlipid is that it can be dosed at 3 g/kg per day, unlike Omegaven, and may be more likely to meet the lipid requirement of neonates.

In summary, the current FDA-approved soy-based lipid product was not designed to meet the nutritional needs of the preterm infant. An ideal lipid emulsion would provide adequate concentrations of polyunsaturated fatty acids, promote growth, be free of phytosterols, and minimize inflammation and other adverse sequelae. SMOFlipid may be more likely to meet the DHA and ARA requirement of the premature neonate. A mixed lipid emulsion dosed at 3 g/kg per day may improve growth and long-term neurodevelopment and reduce the incidence of parenteral nutrition associated liver disease along with other common neonatal diseases. In turn, this may reduce health care related costs. Appropriately powered, well-designed randomized controlled trials with long-term follow-up are needed to evaluate this new lipid emulsion.

References

1. J Pediatr Gastroenterol Nutr. 2010 Oct;51(4):514-21.

2. Nutr Clin Pract. 2012 Dec;27(6):817-24.

3. J Pediatr Gastroenterol Nutr. 2014 Apr;58(4):417-27.

4. JPEN J Parenter Enteral Nutr. 2016 Mar;40(3):374-82.

5. JPEN J Parenter Enteral Nutr. 2014 Aug;38(6):682-92.

Dr. Calkins is an assistant professor of pediatrics in the division of neonatology at the University of California, Los Angeles. She receives research funding from Fresenius Kabi, the German manufacturer of the products described in this article. The terms of this arrangement have been reviewed by UCLA in accordance with its conflict of interest policy. Because there is only one manufacturer for some of the products discussed in this article, for clarity we have chosen to use brand names rather than generic names. Email Dr. Calkins at [email protected].

Premature neonates are at high risk for growth failure and a host of morbidities including sepsis, chronic lung disease, necrotizing enterocolitis, retinopathy of prematurity, cholestasis, and neurodevelopmental impairment. Nutrition plays an important role in modulating disease. Virtually all extremely low birth weight neonates (birth weight less than 1 kg) receive parenteral nutrition and intravenous lipids in order to promote optimal nutrition and growth. Intravenous lipids provide nonprotein calories and the essential fatty acids linoleic acid (an omega-6 fatty acid) and alpha-linoleic acid (an omega-3 fatty acid). High omega-6:omega-3 fatty acid ratios promote inflammation and have been associated with various adult-onset diseases, including cardiovascular disease, diabetes, and cancer.

Currently, the only Food and Drug Administration–approved lipid emulsion is entirely soybean based (Intralipid). This lipid emulsion contains a high omega-6:omega-3 fatty acid ratio, high concentrations of linoleic and alpha-linoleic acid, and lacks arachidonic acid (ARA, an omega-6 fatty acid) and docosahexaenoic acid (DHA, an omega-3 fatty acid). Moreover, soybean oil contains a small amount of vitamin E, an antioxidant which helps prevent lipid peroxidation and oxidative stress. A non–FDA approved lipid emulsion (SMOFlipid) is currently being prescribed to children, including preterm neonates, in Europe. SMOFlipid contains a “mix” of various oils (30% soy, 15% fish, 30% coconut, and 25% olive oil) and a higher concentration of Vitamin E (48 mg/dL vs. 38 mg/dL). In comparison with soybean oil, SMOFlipid’s fatty acid content more closely resembles breast milk with a more physiologically appropriate omega-6:omega-3 fatty acid ratio. As a result, SMOFlipid theoretically may have the capability to modulate disease by decreasing systemic inflammation and tissue injury.

Dr. Kara L. Calkins

In small retrospective and randomized controlled trials, preterm neonates who received SMOFlipid have increased ARA, DHA, and vitamin E concentrations and decreased markers of oxidative stress, compared with neonates who received standard soybean oil1-3. Improving the DHA and ARA status in preterm neonates has several theoretical advantages. DHA and ARA are preferentially transferred to the fetus during the third trimester of pregnancy, and found in significant quantities in the brain, retina, and breast milk. Under normal physiological conditions, linoleic and alpha-linoleic acid, which cannot be synthesized de novo, are metabolized to ARA and DHA. Despite being provided with linoleic and alpha-linoleic acid in intravenous soybean oil, preterm neonates develop ARA and DHA deficiencies. Preterm neonates lack the necessary enzymatic machinery (due to immature livers) to convert these essential fatty acids into their downstream products. ARA and DHA deficiencies have been linked to the development of bronchopulmonary dysplasia and retinopathy of prematurity. Infant formulas now contain DHA and ARA, and have been associated with improved visual and cognitive outcomes. Because very low birth weight neonates are at high risk for growth failure and neurological impairment along with other comorbidities, many people believe that intravenous lipids should contain pre-formed ARA and DHA. However, it remains to be determined if an improved fatty acid profile in this population translates into better long-term outcomes.

Soybean-based lipids also have been heavily criticized for their high concentrations of hepatotoxic phytosterols, which have been linked to parenteral nutrition associated liver disease (PNALD). Neonates are at high risk for PNALD because of immature livers and the need for prolonged courses of parenteral nutrition. Twenty percent to 60% of premature neonates and children with gastrointestinal disorders will develop PNALD. In neonates with short bowel syndrome, the highest-risk subgroup, 70% will develop PNALD and 20% will progress to liver failure. Once end-stage liver disease develops, an isolated liver or combined small bowel-liver transplant may be the only life-saving measure. Due to the high mortality of end-stage PNALD, small size of transplant candidates, and shortage of organ donors, 50% of children awaiting a transplant will not survive. Five-year post-transplant survival is 60%-70% and fraught with a complex lifestyle. Transplants also carry a high price tag with an estimated cost of $1.5-$1.9 million in the first year.

In comparison with soybean oil, SMOFlipid has a reduced concentration of phytosterols (48 mg/L vs. 343 mg/L). Phytosterols are only found in plant food sources and approximately 5%-10% of phytosterols are absorbed in the intestine. As a result, in a healthy child, they are present at minimal concentrations in the bloodstream. Children receiving parenteral nutrition and with PNALD have higher concentrations of phytosterols, compared with controls. High concentrations of phytosterol reduce the expression of hepatic bilirubin and bile acid transporters. As a result, as phytosterol concentrations rise, bile acids and bilirubin are retained in the liver, causing cholestasis. Like phytosterols, cytokines cause a decrease in biliary flow. Hence, soybean oil’s high concentration of phytosterols and omega-6 fatty acids, which causes a shift toward a proinflammatory state, act synergistically to promote liver injury. SMOFlipid’s reduced phytosterol content potentially may have important implications with regards to the development and progression of PNALD. In randomized controlled trials, neonates who received SMOFlipid had decreased phytosterol concentrations and improved liver function tests, compared with neonates who received soybean oil. Larger studies are needed to determine if SMOFlipid reduces the incidence or severity of PNALD.

 

 

©herjua/Thinkstock.com

In children with advanced PNALD, low dose fish oil monotherapy (Omegaven) has been shown to biochemically reverse cholestasis4,5. Like SMOFlipid, Omegaven is not FDA approved and its use is restricted throughout the United States. Omegaven is dosed at 1 g/kg per day, lacks phytosterols, and contains high concentrations of the anti-inflammatory omega-3 fatty acids DHA and eicosapentaenoic acid, and vitamin E. Based on the assumption that reducing the liver’s exposure to phytosterols and omega-6 fatty acids treats PNALD, it has now become common clinical practice in many neonatal intensive care units to prescribe low dose soybean oil for PNALD prevention. While observational data suggests low dose soybean oil (1 g/kg per day or less) reduces the incidence of PNALD, randomized controlled trials have not demonstrated a change in cholestasis. Lipid sparing (fish or soy) is not without risks, particularly in high-risk populations such as preterm neonates. Inadequate lipid intake during a period of rapid growth and development could cause a fatty acid deficiency and impair growth and neurodevelopment. The central nervous system contains high concentrations of lipids, which are important for cell structure and function and gene transcription. One of the advantages of SMOFlipid is that it can be dosed at 3 g/kg per day, unlike Omegaven, and may be more likely to meet the lipid requirement of neonates.

In summary, the current FDA-approved soy-based lipid product was not designed to meet the nutritional needs of the preterm infant. An ideal lipid emulsion would provide adequate concentrations of polyunsaturated fatty acids, promote growth, be free of phytosterols, and minimize inflammation and other adverse sequelae. SMOFlipid may be more likely to meet the DHA and ARA requirement of the premature neonate. A mixed lipid emulsion dosed at 3 g/kg per day may improve growth and long-term neurodevelopment and reduce the incidence of parenteral nutrition associated liver disease along with other common neonatal diseases. In turn, this may reduce health care related costs. Appropriately powered, well-designed randomized controlled trials with long-term follow-up are needed to evaluate this new lipid emulsion.

References

1. J Pediatr Gastroenterol Nutr. 2010 Oct;51(4):514-21.

2. Nutr Clin Pract. 2012 Dec;27(6):817-24.

3. J Pediatr Gastroenterol Nutr. 2014 Apr;58(4):417-27.

4. JPEN J Parenter Enteral Nutr. 2016 Mar;40(3):374-82.

5. JPEN J Parenter Enteral Nutr. 2014 Aug;38(6):682-92.

Dr. Calkins is an assistant professor of pediatrics in the division of neonatology at the University of California, Los Angeles. She receives research funding from Fresenius Kabi, the German manufacturer of the products described in this article. The terms of this arrangement have been reviewed by UCLA in accordance with its conflict of interest policy. Because there is only one manufacturer for some of the products discussed in this article, for clarity we have chosen to use brand names rather than generic names. Email Dr. Calkins at [email protected].

References

References

Publications
Publications
Topics
Article Type
Display Headline
Advances in IV nutrition for very low birth weight neonates
Display Headline
Advances in IV nutrition for very low birth weight neonates
Legacy Keywords
preemies, iv, lipids, VLBW, babies
Legacy Keywords
preemies, iv, lipids, VLBW, babies
Sections
Article Source

PURLs Copyright

Inside the Article

Quality Improvement in Clinical Practice

Article Type
Changed
Thu, 03/28/2019 - 15:09
Display Headline
Quality Improvement in Clinical Practice

As Director for Quality Improvement in an academic department, I frequently remind my colleagues that "quality" is not a 4-letter word. Unfortunately, quality is linked in many physicians’ minds to increasing practice complexity and an alphabet soup of acronyms, such as PQRS (Physician Quality Reporting System), MU (meaningful use), and MOC (Maintenance of Certification), among others. Quality improvement (QI) can and should be driven by a desire to improve patient outcomes, professional satisfaction, and operational efficiency, so how should dermatologists respond?

It is helpful to consider why measures of quality are increasingly tied to payment. Conventional wisdom suggests that the American health care system provides poor value. In 2014, total health care expenditures in the United States were $3.0 trillion ($9523 per person), representing 17.5% of the gross domestic product.1 In 1999, the Institute of Medicine estimated that 44,000 to 98,000 individuals die each year due to hospital-based medical errors.2 Noting poor outcomes and high costs, Berwick et al3 proposed the triple aim of improving the experience of care, improving health of populations, and reducing cost. If health care is too expensive and if quality includes outcomes and safety, then improved value of health care must couple cost reduction to QI. Although the future of health care reform is uncertain, it is reasonable to assume that physicians will be expected to care for more patients with fewer dollars. In that context, maximizing operational efficiency and thus economic viability is key. Our challenge is to remain focused on our patients and to identify opportunities to improve the value of their care, both by reducing costs and improving quality.

Health care systems, however, cannot improve with an unhappy and burned-out workforce. Recent data demonstrate high rates of professional burnout among physicians, including dermatologists.4 Bodenheimer and Sinsky5 propose the quadruple aim, which adds improving physician and staff work-life balance to the elements of the triple aim. Burned-out physicians cannot constructively participate in achieving the goals of the triple aim, and physician and staff satisfaction must be a component of any QI paradigm.

The Institute of Medicine has proposed 6 specific aims for improving health care systems: health care should be safe, effective, patient centered, timely, efficient, and equitable.6 These aims, taken together with the quadruple aim, can serve as a foundation for developing QI projects for practices and health systems.

Patient safety is a well-recognized issue in dermatology.7-9 Specimen labeling errors, medication errors, wrong-site surgery, and postprocedure complications are examples of safety issues. Quality improvement directed toward improved professional satisfaction for physicians and staff also is critical. The suggestions offered by Bodenheimer and Sinsky5 are directed to primary care providers but are applicable to many dermatology practices. The American Medical Association’s STEPS Forward initiative provides online tutorials that guide practice improvements aimed at improving professional satisfaction and operational efficiency.10

Patient-centered care need not focus solely on patient satisfaction. Clearly, a physician’s duty is to do what is best for each patient, but patient satisfaction and experience are increasingly common measures of quality. Although evidence suggests that measures of physician-patient communication correlate with patient compliance,11 higher patient satisfaction scores may also correlate with higher cost and increased mortality.12 A practice without happy patients is unlikely to thrive, but initiatives aimed at improving patient-centered care might do well to maximize the quality of communication with patients, rather than to focus solely on satisfaction.

Effective care can be particularly challenging to measure in the absence of widely accepted clinical quality measures. DataDerm measures, appropriate use criteria, and clinical guidelines all may serve to inspire QI projects for a broad range of practice settings. Diagnostic error is particularly challenging, but approaches to improving diagnostic accuracy have been published.13,14 Case reviews may reduce diagnostic errors, and dermatopathologists may consider second-opinion pathologic review of challenging cases.15

Promotion of equitable care is often overlooked as a QI opportunity. Lower socioeconomic status correlates with poorer medical outcomes. For example, melanoma patients who are uninsured or covered by Medicaid present with higher-stage disease, are less likely to be treated, and demonstrate worse survival compared to non-Medicaid insured patients.16 It is important to recognize inequity in health care access and outcomes, and dermatologists can participate in addressing disparities in care.

How can an individual physician proceed? There are general principles that can guide physicians in any practice setting (Table).

Any of us can be forgiven for being frustrated by ever-increasing mandates that purport to address quality and for feeling paralyzed when asked to do our part to improve the value of the American health care system. The key to successful QI is to continually identify small processes that can be improved while focusing on one’s patients, colleagues, staff, and community. A well-designed process can and will result in better care, lower costs, and happier physicians and staff. With time, disparate and coordinated efforts among physicians and systems can inform and promote national QI efforts.

References

 

1. Martin AB, Hartman M, Benson J, et al. National health spending in 2014: faster growth driven by coverage expansion and prescription drug spending. Health Aff (Millwood). 2016;35:150-160.

2. Kohn LT, Corrigan JM, Donaldson MS, eds. To Err is Human: Building a Safer Health System. Vol 627. Washington, DC: National Academy Press; 2000.

3. Berwick DM, Nolan TW, Whittington J. The triple aim: care, health and cost. Health Aff (Millwood). 2008;27:759-769.

4. Shanafelt TD, Hasan O, Dyrbye LN, et al. Changes in burnout and satisfaction with work-life balance in physicians and the general us working population between 2011 and 2014. Mayo Clin Proc. 2015;90:1600-1613.

5. Bodenheimer T, Sinsky C. From triple to quadruple aim: care of the patient requires care of the provider. Ann Fam Med. 2014;12:573-576.

6. Committee on Quality of Health Care in America, Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academy Press; 2001.

7. Elston DM, Taylor JS, Coldiron B, et al. Part I. patient safety and the dermatologist. J Am Acad Dermatol. 2009;61:179-190.

8. Elston DM, Stratman E, Johnson-Jahangir H, et al. Part II. opportunities for improvement in patient safety. J Am Acad Dermatol. 2009;61:193-205.

9. Watson AJ, Redbord K, Taylor JS, et al. Medical error in dermatology practice: development of a classification system to drive priority setting in patient safety efforts. J Am Acad Dermatol. 2012;68:729-737.

10. American Medical Association. STEPS Forward website. http://www.stepsforward.org. Accessed March 8, 2016.

11. Zolnierick KB, DiMatteo MR. Physician communication and patient adherence to treatment: a meta-analysis. Med Care. 2009;47:826-834.

12. Fenton JJ, Jerant AF, Bertakis KD, et al. The cost of satisfaction: a national study of patient satisfaction, health care utilization, expenditures, and mortality. Arch Intern Med. 2012;172:405-411.

13. Dunbar M, Helms SE, Brodell RT. Reducing cognitive errors in dermatology: can anything be done? J Am Acad Dermatol. 2013;69:810-813.

14. Groszkruger D. Diagnostic error: untapped potential for improving patient safety. J Healthc Risk Manag. 2014;34:38-43.

15. Middleton LP, Feeley TW, Albright HW, et al. Second-opinion pathologic review is a patient safety mechanism that helps reduce error and decrease waste. J Oncol Pract. 2014;10:275-280.

16. Amini A, Rusthoven CG, Waxweiler TV, et al. Association of health insurance with outcomes in adults ages 18-64 years with melanoma in the United States. J Am Acad Dermatol. 2016;74:309-316.

Article PDF
Author and Disclosure Information

 

Daniel D. Bennett, MD

From the Department of Dermatology, University of Wisconsin School of Medicine and Public Health, Madison.

The author reports no conflict of interest.

Correspondence: Daniel D. Bennett, MD, 451 Junction Rd, Room G113, Madison, WI 53717 ([email protected]).

Issue
Cutis - 97(4)
Publications
Topics
Page Number
255-256
Legacy Keywords
quality improvement, practice management, patient outcome, professional satisfaction, operational efficiency, quality measure, health care
Sections
Author and Disclosure Information

 

Daniel D. Bennett, MD

From the Department of Dermatology, University of Wisconsin School of Medicine and Public Health, Madison.

The author reports no conflict of interest.

Correspondence: Daniel D. Bennett, MD, 451 Junction Rd, Room G113, Madison, WI 53717 ([email protected]).

Author and Disclosure Information

 

Daniel D. Bennett, MD

From the Department of Dermatology, University of Wisconsin School of Medicine and Public Health, Madison.

The author reports no conflict of interest.

Correspondence: Daniel D. Bennett, MD, 451 Junction Rd, Room G113, Madison, WI 53717 ([email protected]).

Article PDF
Article PDF
Related Articles

As Director for Quality Improvement in an academic department, I frequently remind my colleagues that "quality" is not a 4-letter word. Unfortunately, quality is linked in many physicians’ minds to increasing practice complexity and an alphabet soup of acronyms, such as PQRS (Physician Quality Reporting System), MU (meaningful use), and MOC (Maintenance of Certification), among others. Quality improvement (QI) can and should be driven by a desire to improve patient outcomes, professional satisfaction, and operational efficiency, so how should dermatologists respond?

It is helpful to consider why measures of quality are increasingly tied to payment. Conventional wisdom suggests that the American health care system provides poor value. In 2014, total health care expenditures in the United States were $3.0 trillion ($9523 per person), representing 17.5% of the gross domestic product.1 In 1999, the Institute of Medicine estimated that 44,000 to 98,000 individuals die each year due to hospital-based medical errors.2 Noting poor outcomes and high costs, Berwick et al3 proposed the triple aim of improving the experience of care, improving health of populations, and reducing cost. If health care is too expensive and if quality includes outcomes and safety, then improved value of health care must couple cost reduction to QI. Although the future of health care reform is uncertain, it is reasonable to assume that physicians will be expected to care for more patients with fewer dollars. In that context, maximizing operational efficiency and thus economic viability is key. Our challenge is to remain focused on our patients and to identify opportunities to improve the value of their care, both by reducing costs and improving quality.

Health care systems, however, cannot improve with an unhappy and burned-out workforce. Recent data demonstrate high rates of professional burnout among physicians, including dermatologists.4 Bodenheimer and Sinsky5 propose the quadruple aim, which adds improving physician and staff work-life balance to the elements of the triple aim. Burned-out physicians cannot constructively participate in achieving the goals of the triple aim, and physician and staff satisfaction must be a component of any QI paradigm.

The Institute of Medicine has proposed 6 specific aims for improving health care systems: health care should be safe, effective, patient centered, timely, efficient, and equitable.6 These aims, taken together with the quadruple aim, can serve as a foundation for developing QI projects for practices and health systems.

Patient safety is a well-recognized issue in dermatology.7-9 Specimen labeling errors, medication errors, wrong-site surgery, and postprocedure complications are examples of safety issues. Quality improvement directed toward improved professional satisfaction for physicians and staff also is critical. The suggestions offered by Bodenheimer and Sinsky5 are directed to primary care providers but are applicable to many dermatology practices. The American Medical Association’s STEPS Forward initiative provides online tutorials that guide practice improvements aimed at improving professional satisfaction and operational efficiency.10

Patient-centered care need not focus solely on patient satisfaction. Clearly, a physician’s duty is to do what is best for each patient, but patient satisfaction and experience are increasingly common measures of quality. Although evidence suggests that measures of physician-patient communication correlate with patient compliance,11 higher patient satisfaction scores may also correlate with higher cost and increased mortality.12 A practice without happy patients is unlikely to thrive, but initiatives aimed at improving patient-centered care might do well to maximize the quality of communication with patients, rather than to focus solely on satisfaction.

Effective care can be particularly challenging to measure in the absence of widely accepted clinical quality measures. DataDerm measures, appropriate use criteria, and clinical guidelines all may serve to inspire QI projects for a broad range of practice settings. Diagnostic error is particularly challenging, but approaches to improving diagnostic accuracy have been published.13,14 Case reviews may reduce diagnostic errors, and dermatopathologists may consider second-opinion pathologic review of challenging cases.15

Promotion of equitable care is often overlooked as a QI opportunity. Lower socioeconomic status correlates with poorer medical outcomes. For example, melanoma patients who are uninsured or covered by Medicaid present with higher-stage disease, are less likely to be treated, and demonstrate worse survival compared to non-Medicaid insured patients.16 It is important to recognize inequity in health care access and outcomes, and dermatologists can participate in addressing disparities in care.

How can an individual physician proceed? There are general principles that can guide physicians in any practice setting (Table).

Any of us can be forgiven for being frustrated by ever-increasing mandates that purport to address quality and for feeling paralyzed when asked to do our part to improve the value of the American health care system. The key to successful QI is to continually identify small processes that can be improved while focusing on one’s patients, colleagues, staff, and community. A well-designed process can and will result in better care, lower costs, and happier physicians and staff. With time, disparate and coordinated efforts among physicians and systems can inform and promote national QI efforts.

As Director for Quality Improvement in an academic department, I frequently remind my colleagues that "quality" is not a 4-letter word. Unfortunately, quality is linked in many physicians’ minds to increasing practice complexity and an alphabet soup of acronyms, such as PQRS (Physician Quality Reporting System), MU (meaningful use), and MOC (Maintenance of Certification), among others. Quality improvement (QI) can and should be driven by a desire to improve patient outcomes, professional satisfaction, and operational efficiency, so how should dermatologists respond?

It is helpful to consider why measures of quality are increasingly tied to payment. Conventional wisdom suggests that the American health care system provides poor value. In 2014, total health care expenditures in the United States were $3.0 trillion ($9523 per person), representing 17.5% of the gross domestic product.1 In 1999, the Institute of Medicine estimated that 44,000 to 98,000 individuals die each year due to hospital-based medical errors.2 Noting poor outcomes and high costs, Berwick et al3 proposed the triple aim of improving the experience of care, improving health of populations, and reducing cost. If health care is too expensive and if quality includes outcomes and safety, then improved value of health care must couple cost reduction to QI. Although the future of health care reform is uncertain, it is reasonable to assume that physicians will be expected to care for more patients with fewer dollars. In that context, maximizing operational efficiency and thus economic viability is key. Our challenge is to remain focused on our patients and to identify opportunities to improve the value of their care, both by reducing costs and improving quality.

Health care systems, however, cannot improve with an unhappy and burned-out workforce. Recent data demonstrate high rates of professional burnout among physicians, including dermatologists.4 Bodenheimer and Sinsky5 propose the quadruple aim, which adds improving physician and staff work-life balance to the elements of the triple aim. Burned-out physicians cannot constructively participate in achieving the goals of the triple aim, and physician and staff satisfaction must be a component of any QI paradigm.

The Institute of Medicine has proposed 6 specific aims for improving health care systems: health care should be safe, effective, patient centered, timely, efficient, and equitable.6 These aims, taken together with the quadruple aim, can serve as a foundation for developing QI projects for practices and health systems.

Patient safety is a well-recognized issue in dermatology.7-9 Specimen labeling errors, medication errors, wrong-site surgery, and postprocedure complications are examples of safety issues. Quality improvement directed toward improved professional satisfaction for physicians and staff also is critical. The suggestions offered by Bodenheimer and Sinsky5 are directed to primary care providers but are applicable to many dermatology practices. The American Medical Association’s STEPS Forward initiative provides online tutorials that guide practice improvements aimed at improving professional satisfaction and operational efficiency.10

Patient-centered care need not focus solely on patient satisfaction. Clearly, a physician’s duty is to do what is best for each patient, but patient satisfaction and experience are increasingly common measures of quality. Although evidence suggests that measures of physician-patient communication correlate with patient compliance,11 higher patient satisfaction scores may also correlate with higher cost and increased mortality.12 A practice without happy patients is unlikely to thrive, but initiatives aimed at improving patient-centered care might do well to maximize the quality of communication with patients, rather than to focus solely on satisfaction.

Effective care can be particularly challenging to measure in the absence of widely accepted clinical quality measures. DataDerm measures, appropriate use criteria, and clinical guidelines all may serve to inspire QI projects for a broad range of practice settings. Diagnostic error is particularly challenging, but approaches to improving diagnostic accuracy have been published.13,14 Case reviews may reduce diagnostic errors, and dermatopathologists may consider second-opinion pathologic review of challenging cases.15

Promotion of equitable care is often overlooked as a QI opportunity. Lower socioeconomic status correlates with poorer medical outcomes. For example, melanoma patients who are uninsured or covered by Medicaid present with higher-stage disease, are less likely to be treated, and demonstrate worse survival compared to non-Medicaid insured patients.16 It is important to recognize inequity in health care access and outcomes, and dermatologists can participate in addressing disparities in care.

How can an individual physician proceed? There are general principles that can guide physicians in any practice setting (Table).

Any of us can be forgiven for being frustrated by ever-increasing mandates that purport to address quality and for feeling paralyzed when asked to do our part to improve the value of the American health care system. The key to successful QI is to continually identify small processes that can be improved while focusing on one’s patients, colleagues, staff, and community. A well-designed process can and will result in better care, lower costs, and happier physicians and staff. With time, disparate and coordinated efforts among physicians and systems can inform and promote national QI efforts.

References

 

1. Martin AB, Hartman M, Benson J, et al. National health spending in 2014: faster growth driven by coverage expansion and prescription drug spending. Health Aff (Millwood). 2016;35:150-160.

2. Kohn LT, Corrigan JM, Donaldson MS, eds. To Err is Human: Building a Safer Health System. Vol 627. Washington, DC: National Academy Press; 2000.

3. Berwick DM, Nolan TW, Whittington J. The triple aim: care, health and cost. Health Aff (Millwood). 2008;27:759-769.

4. Shanafelt TD, Hasan O, Dyrbye LN, et al. Changes in burnout and satisfaction with work-life balance in physicians and the general us working population between 2011 and 2014. Mayo Clin Proc. 2015;90:1600-1613.

5. Bodenheimer T, Sinsky C. From triple to quadruple aim: care of the patient requires care of the provider. Ann Fam Med. 2014;12:573-576.

6. Committee on Quality of Health Care in America, Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academy Press; 2001.

7. Elston DM, Taylor JS, Coldiron B, et al. Part I. patient safety and the dermatologist. J Am Acad Dermatol. 2009;61:179-190.

8. Elston DM, Stratman E, Johnson-Jahangir H, et al. Part II. opportunities for improvement in patient safety. J Am Acad Dermatol. 2009;61:193-205.

9. Watson AJ, Redbord K, Taylor JS, et al. Medical error in dermatology practice: development of a classification system to drive priority setting in patient safety efforts. J Am Acad Dermatol. 2012;68:729-737.

10. American Medical Association. STEPS Forward website. http://www.stepsforward.org. Accessed March 8, 2016.

11. Zolnierick KB, DiMatteo MR. Physician communication and patient adherence to treatment: a meta-analysis. Med Care. 2009;47:826-834.

12. Fenton JJ, Jerant AF, Bertakis KD, et al. The cost of satisfaction: a national study of patient satisfaction, health care utilization, expenditures, and mortality. Arch Intern Med. 2012;172:405-411.

13. Dunbar M, Helms SE, Brodell RT. Reducing cognitive errors in dermatology: can anything be done? J Am Acad Dermatol. 2013;69:810-813.

14. Groszkruger D. Diagnostic error: untapped potential for improving patient safety. J Healthc Risk Manag. 2014;34:38-43.

15. Middleton LP, Feeley TW, Albright HW, et al. Second-opinion pathologic review is a patient safety mechanism that helps reduce error and decrease waste. J Oncol Pract. 2014;10:275-280.

16. Amini A, Rusthoven CG, Waxweiler TV, et al. Association of health insurance with outcomes in adults ages 18-64 years with melanoma in the United States. J Am Acad Dermatol. 2016;74:309-316.

References

 

1. Martin AB, Hartman M, Benson J, et al. National health spending in 2014: faster growth driven by coverage expansion and prescription drug spending. Health Aff (Millwood). 2016;35:150-160.

2. Kohn LT, Corrigan JM, Donaldson MS, eds. To Err is Human: Building a Safer Health System. Vol 627. Washington, DC: National Academy Press; 2000.

3. Berwick DM, Nolan TW, Whittington J. The triple aim: care, health and cost. Health Aff (Millwood). 2008;27:759-769.

4. Shanafelt TD, Hasan O, Dyrbye LN, et al. Changes in burnout and satisfaction with work-life balance in physicians and the general us working population between 2011 and 2014. Mayo Clin Proc. 2015;90:1600-1613.

5. Bodenheimer T, Sinsky C. From triple to quadruple aim: care of the patient requires care of the provider. Ann Fam Med. 2014;12:573-576.

6. Committee on Quality of Health Care in America, Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academy Press; 2001.

7. Elston DM, Taylor JS, Coldiron B, et al. Part I. patient safety and the dermatologist. J Am Acad Dermatol. 2009;61:179-190.

8. Elston DM, Stratman E, Johnson-Jahangir H, et al. Part II. opportunities for improvement in patient safety. J Am Acad Dermatol. 2009;61:193-205.

9. Watson AJ, Redbord K, Taylor JS, et al. Medical error in dermatology practice: development of a classification system to drive priority setting in patient safety efforts. J Am Acad Dermatol. 2012;68:729-737.

10. American Medical Association. STEPS Forward website. http://www.stepsforward.org. Accessed March 8, 2016.

11. Zolnierick KB, DiMatteo MR. Physician communication and patient adherence to treatment: a meta-analysis. Med Care. 2009;47:826-834.

12. Fenton JJ, Jerant AF, Bertakis KD, et al. The cost of satisfaction: a national study of patient satisfaction, health care utilization, expenditures, and mortality. Arch Intern Med. 2012;172:405-411.

13. Dunbar M, Helms SE, Brodell RT. Reducing cognitive errors in dermatology: can anything be done? J Am Acad Dermatol. 2013;69:810-813.

14. Groszkruger D. Diagnostic error: untapped potential for improving patient safety. J Healthc Risk Manag. 2014;34:38-43.

15. Middleton LP, Feeley TW, Albright HW, et al. Second-opinion pathologic review is a patient safety mechanism that helps reduce error and decrease waste. J Oncol Pract. 2014;10:275-280.

16. Amini A, Rusthoven CG, Waxweiler TV, et al. Association of health insurance with outcomes in adults ages 18-64 years with melanoma in the United States. J Am Acad Dermatol. 2016;74:309-316.

Issue
Cutis - 97(4)
Issue
Cutis - 97(4)
Page Number
255-256
Page Number
255-256
Publications
Publications
Topics
Article Type
Display Headline
Quality Improvement in Clinical Practice
Display Headline
Quality Improvement in Clinical Practice
Legacy Keywords
quality improvement, practice management, patient outcome, professional satisfaction, operational efficiency, quality measure, health care
Legacy Keywords
quality improvement, practice management, patient outcome, professional satisfaction, operational efficiency, quality measure, health care
Sections
Article PDF Media